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Abstract 
Bromodeoxyuridine (BrdU) is a thymidiie analogue that incorporates into DNA of 
dividing cells during the S-phase of the cell cycle. Previous work in laboratories 
reported that treatment with lOyM BrdU in the human lung carcinoma cell line 
(DLKP) resulted in increased expression of the cytoskeletal proteins Keratin 8 and 
18 and the cell adhesion proteins a 2 and 1 integrin. 
This study investigated protein expression changes in differentiating DLKP cells 
following exposure to 10yM BrdU. DLKP cells were grown in culture flasks and 
harvested after 7 days exposure to BrdU. Two-dimensional gel electrophoresis was 
used to investigate BrdU specific changes in the proteome of DLKP BrdU treated 
and control cells. 
Cy3-labeled DLKP control were combined with Cy-5 labeled BrdU DLKP treated 
proteins and separated on the same 2-D gel along with a Cy-2 labelled mixture of 
both samples as an internal standard. Using DIGE technology, the statistically 
significant comparisons of each protein abundance was made over three biological 
replicates. 43 protein spots were identified as differentially regulated. Among the 
43 protein spots, 25 were found to be up-regulated and 18 were found to be down- 
regulated. 
Gel plugs of the differentially regulated proteins spots were subjected to optimised 
in-gel digestionlsample preparation methods. Samples were analysed by Matrix- 
assisted laser desorption/ionisation-time of flight (MALDI) and tandem (ion trap) 
mass spectrometry. Optimisation parameters included sample clean up and 
concentration, internal calibration and re-calibration methods, increased volume gel 
plug picking and liquid chromatography run times. 
Use of the optimised methods allowed the identification of 23 differentially 
regulated proteins. The identified proteins are involved in important biological 
processes such as cytoskeletal/stmctural organisation, cell growth, maintenance, 
metabolism and immune response 
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1.0 Introduction 
1.1 General Introduction to Proteomics 
The importance of changes in protein expression and/or function has long been 
appreciated in environmental chemical-induced toxicity and cancer. For many 
years, however, profiling protein targets of toxic chemicals has been a nearly 
impossible task. The development of both matrix-assisted laser desorption- 
ionisation (MALDI) (Karas et aL, 1988) and electrospray ionisation (ESI) (Fern et 
al., 1989) has now made it possible for high throughput analysis and identification 
of proteins. Proteomics focuses on the identification of a large number of proteins 
from cellular extracts. Biological samples normally contain numerous proteins, and 
the complexity of these materials requires separation steps. The most common 
method involves the following steps: separation of proteins from a given biological 
sample by gel electrophoresis (Blackstock et al., 1999), excision of spots from the 
gel and digestion by trypsin (Quadroni et aL, 1999), and extraction from the gel 
followed by analysis by mass spectrometry (Yates et al., 2000). 
Two-Dimensional Electrophoresis (2-DE) combined with protein identification by 
mass spec$ometry (MS) is currently one of the main workhorses for proteomics. 
Proteome analysis is technically challenging, as the number of different proteins 
expressed at a given time under defined biological conditions is likely to be in the 
range of several thousand for simple prokaryotic organisms and up to at least 10, 
000 in eukaryotic cell extracts. Moreover, current proteomic studies have revealed 
that the majority of identified proteins are abundant housekeeping proteins that are 
present in numbers of 10' to lo6 copiesper cell, whereas proteins such as receptor 
molecules that are present in much lower concentrations (typically < 100 molecules 
per cell) are usually not detected. Improved methods for enrichment of low- 
abundance proteins (i.e. prefiactionation) as well as more sensitive detection and 
quantitation methods are required. 
2-DE couples Isoelectric Focusing (IEF) in the first dimension with SDS-PAGE in 
the second dimension which enables the separation of complex mixtures of proteins 
according to their Isoelectric Point (pl), Molecular weight (M,), solubility and 
relative abundance. 2-DE can routinely resolve -2000 proteins simultaneously and 
detect < 1 ng of proteinper spot. It also delivers a map of intact proteins, which 
reflects changes in protein expression level, isoforms or Post Translation 
Modification (PTM). This is in contrast to LC-MS/MS based methods, which 
perform analysis on peptides, where M, andpI information is lost and where stable 
isotope labelling is required for quantitative analysis. One of the greatest strengths 
of 2-DE is its capability to study proteins that have undergone some of PTM (such 
as pbophorylation, glycosylation or limited proteolysis) and which can, in many 
instances, be readily located in 2-DE gels as they appear as distinct spot trains in 
the horizontal and/or vertical axis of the 2-DE gel. In addition, 2-DE not only 
provides information on protein modifications and/or changes in their expression 
levels, but also permits the isolation of proteins for further structural analyses by 
MALDI-TOF MS, ESI-MS, NMR (Rantalainen et al., 2006) or Edrnan 
Microsequencing (Edman, et al., 1967). The major steps of the 2-DE-MS workflow 
include (1) sample preparation and protein solubilisation; (2) protein separation by 
2-DE; (3) protein detection and quantification; (4) computer assisted analysis of 2- 
DE patterns; (5) protein identification and characterisation (Dunn et al., 1993). 
1.2 Sample preparation 
To take advantage of the high resolution of 2-DE, proteins of the sample have to be 
denatured, disaggregrated, reduced and solubilised to achieve complete disruption 
of the molecular interactions and to ensure that each spot represents an individual 
polypeptide. The major problems concerning the visualisation of proteins .from total 
cell line extracts is the high dynamic range of proteins with respect to M,, pZ and 
solubility. Although a one-step procedure for protein extraction would be highly 
desireable with regard to simplicity and reproducibility, there is no single method 
of sample preparation that can be universally applied to all kinds of samples 
analyzed by 2-DE (Dunn et al., 1993). Sample preparation should be as simple a s  
possible to increase reproducibility and protein modifications during sample 
preparation must be minimised, because they might result in artifactual spots on 2- 
D gels. In particular, proteolytic enzymes in the sample must be inactivated. 
Samples containing urea must not be heated, in order to avoid charge 
heterogeneities caused by carbamylation of the proteins by isocyanate formed in the 
decomposition of urea (Dunn et al., 1993). The three fundamental steps in sample 
preparation are cell disruption, inactivation or removal of interfering substances, 
and solubilisation of the proteins (Dunn et al., 2004). 
Cell disruption can be achieved by detergent lysis, osmotic lysis, freeze thaw 
cycling, sonication, grinding with or without liquid nitrogen, nitrogen cavitation or 
a rotating blade homogeniser. Typically microbial cells or plant tissues require 
harsh conditions for cell lysis due to their cell walls while more gentle methods can 
be applied to mammalian cells. During or after cell lysis, interfering compounds 
such as proteolytic enzymes, salts, lipids, nucleic acids and/or highly abundant 
proteins have to removed or inactivated. The two most important parameters are 
salt and proteolysis. 
Proteases must be inactivated to prevent protein degradation that otherwise may 
result in artifactual spots and loss of high M, proteins. Protease inhibitors are 
usually added but they may modify proteins and cause charge artifacts (Dunn et al., 
1993). Schuchard et al., (2005) described isofom profile changes in plasma 
proteins on 2D-gels with the inclusion of 4-(2-Aminoethyl) Benzenesulfonyl 
Fluoride (AENSF) (serine protease inhibitor) which covalently modifies serine 
residues. Other remedies are boiling the sample in SDS-buffer (without urea) or 
inactivating proteases by low pH (ice-cold TCA precipitation). 
Salt ions may interfere with electrophoretic separation and should be removed if 
their concentration is too high (>100mM). This is particularly a problem when 
samples are applied by sample in-gel rehydration. Higher salt concentrations can be 
tolerated by cup loading, however low voltages (approximately 150V) have to be 
applied for several hours otherwise proteins may precipitate at the site of sample 
application. Salt will increase the conductivity of the Isoelectric Focusing (IEF) gel 
thus prolonging the time required to reach the steady-state. Salt removal can be 
achieved by spin-dialysis or precipitation (TCA or cold acetone), 2-D clean-up kits 
(e.g. from GE Healthcare) or dilution of the sample below a critical salt 
concentration followed by application of a larger sample volume onto the 
Irnmobilised pH Gradient (IPG) gel. The sample is then desalted in the gel by 
applying low voltages (1 00V) at the beginning of the run for up to several hours 
and replacing the filter paper pads beneath the electrodes (where the salt ions have 
collected) several times (Gorg et al., 2000). High amounts of lipids may interact 
with membrane proteins and consume detergents. High speed centrifugation of the 
sample and subsequent removal of the lipid layer avoids this problem. 
Polysaccarides and nucleic acids can interact with canier arnpholytes and proteins 
resulting in streaky 2-D patterns. These macromolecules may also increase the 
viscosity of the solution and obstruct the pores of the polyacrylamide gels. The 
nucleic acids can be removed by their digestion with RNAses and DNAses. 
Sometimes highly abundant proteins present problems since they impair separation 
and detection of lower abundant proteins by limiting the amount of these proteins to 
be loaded onto the 2-D gel and/or masking them on the 2-D pattern. Albumin 
constitutes up to 60% of the bulk protein in plasma and is a major problem (Pieper 
et al., 2003). There are commercially available albumin removal kits but one has to 
be aware that these kits remove proteins other than albumin (Simpson et al., 2004). 
1.2.1 Protein solubilisation 
After cell disruption and/or removal of interfering compounds, the individual 
polypeptides must be denatured and reduced to disrupt intra- and intermolecular 
interactions and solubilised while maintaining the inherent cliarge properties. 
Sample solubilisation is usually carried out in a buffer containing chaotropes (e.g. 
urea and/or thiourea), non-ionic and/or zwitterionic detergents (e.g. CHAPS), 
reducing agents, carrier ampholyte (CA) and depending on the sample, protease 
inhibitors. The most popular sample solubilisation buffer is based on O'Farrell's 
lysis buffer ( O'Farrell et al., 1975) and modifications thereof (9M Urea, 2-4% 
CHAPS, l%DTT and 2% v/v CA). 
Urea is quite effective in disrupting hydrogen bonds, leading to protein unfolding 
and denaturation. However, urea lysis buffers are not ideal for the solubilisation of 
all protein classes, particularly for membrane or other hydrophobic proteins. 
Improvement in the solubilisation of hydrophobic proteins has come with the use of 
thiourea (Rabilloud et al., 1998) and new zwitteronic detergents such as 
sulfobetaines (Luche et al., 2003). Thiourea is better suited for breaking 
hydrophobic interactions but its usefulness is limited due to its poor solubility in 
water. However it is more soluble in concentrated urea solutions. Currently the best 
solution for solubilisation is a combination of 5-7M urea and 2M thiourea. The 
major problem associated with urea in aqueous solutions is that urea exists in 
equilibrium with ammonium (iso)cyanate, which can react with the a-amino groups 
of the N-terminus and the &-amino groups of lysine residues, thereby forming 
artifacts such as blocking the N-terminus and introducing charge heterogeneities. 
To prevent this carbamylation reaction temperatures above 37OC have to be avoided 
under all circumstances and CA (2%v/v), which act as cyanate scavengers should 
be included in the urea solution. The zwitterionic detergent CHAPS is effective in 
solubilising very hydrophobic proteins and in combination with urea and thiourea 
have been shown to solubilise at least several integral membrane proteins (Molloy 
et al., 2000). 
Reduction and prevention of re-oxidation of disulfide bonds is a critical step of the 
sample preparation procedure. Reducing agents are necessary for cleavage of intra- 
and intermolecular disulphide bonds to achieve complete protein unfolding. The 
most commonly used reducant is DTT and is applied in excess, i.e. concentrations 
up to 100mM. Unfortunately DTT is a weak acid with pKvalue between 8.5-9, 
which means it will ionise at basic pH and therefore will not allow complete 
resolution in the alkaline gel area due to migration to the anode during IEF. 
1.2.2 Prefractionation procedures 
Since there is no amplification step for proteins analogous to the PCR method for 
amplifyng nucleic acids, and due to the high dynamic range and diversity of 
expressed proteins, it is often preferable to cany out a prefiactionation step to 
reduce the complexity of the sample, enrich for certain proteins such as low-copy 
number proteins or alkaline proteins and to get some information on the topology of 
the proteins. This can be accomplished by (1) isolation of specific cell types ffom a 
tissue, e.g. laser capture micro dissection (LCM) (Zhou et al., 2002), or 
~ ~ 
fluorescence activated cell sorting (FACS) (Li W et al., 2006), (2) isolation of cell 
compartments and/or organelles e.g. by sucrose gradient centrifugation (Zhang et 
al., 2006), (3) selective precipitation of certain protein classes e.g. TCAIacetone 
precipitation for ribosomal proteins (Jiang et ab, 2004), (4)  sequential extraction 
procedures with increasingly powerfUl solubilisation buffers e.g. aqueous buffers, 
organic solvents (ethanol or chloroform/methanol) (Ruth et al., 2006) and 
detergent-based extraction solutions (Williams et al., 2007), ( 5 )  chromatographic 
separation methods e.g phosphoprotein enrichment using Phosphoprotein Protein 
Purification kit (Qiagen) (Laugesen et al., 2006). One major disadvantage of most 
prefractionation procedures lies in cross-contamination between individual 
fractions and in the fact that they are either time consuming, complicated to handle, 
require concentration steps due to elution/dilution procedures and/or do not allow 
more than a few samples in parallel to be processed. Another disadvantage with 
fractionation procedures for the depletion of high abundant proteins for example in 
biomarker discovery can result in the loss of many low abundant proteins too. Zhou 
et a1 (2004) described when albumin is imrnunodepleted, another 63 proteins bound 
to albumin are co-depleted as well which can introduce variability in results and 
possible loss of information. 
1.3 2-Dimensional Electrophoresis (2-DE) 
The prerequisite, but also the challenge for proteome analysis is to separate proteins 
fiom complex biological samples with high reproducibility and high resolution. 
During 2-DE, proteins in complex mixtures are electrophoretically separated 
according to their isoelectric point (PI) and subsequently according to their 
molecular weight by a sequential combination of isoelectric focusing (IEF) and 
sodium-dodecyl sulphate (SDS) polyacrylamide gel electrophoresis (PAGE). 2-DE 
has been used for large-scale protein separation since 1975 (Klose 1975) and allows 
for purification, identification as well as quantification of proteins. 2-DE analysis 
provides several types of information, including molecular weight, pI and quantity. 
1.3.1 First dimension: IEF 
Differences in proteins isoelectric points are the basis of separations by isoelectric 
focusing (IEF). The pI is the pH at which a protein will not migrate in an electric 
field and is determined by the charged groups in the protein. Proteins can cany 
positive, negative or zero charge depending on their local pH, and for every protein 
there is a specific pH at which its net charge is zero (this is its PI). 
IEF represents the first dimension of two-dimensional (2D) electrophoresis, and 
immobilised pH gradient (IPG) strips facilitate this analysis. 
Linear or nonlinear (Bjellqvist et al., 1993) wide pH range (e.g. IPG 3-12), medium 
(e.g. IPG 4-7), narrow (e.g. 4.5-5.5) andlor ultra narrow (e.g. IPG 4.9-5.3). 
IPG's can vary in lengths to accommodate various gel sizes, usually from 7-24cm. 
Besides laboratory-made IPG gels, a variety of commercially available IPG dry 
strips can now be purchased from different suppliers. Ready-made IPG dry strips 
are increasingly popular due to easier handling, better comparability of results and 
exchange of data, and have significantly contributed to the widespread application 
of 2-DE in proteomics. 
1.3.2 IPG strip rehydration and sample application 
Prior to IEF, the IPG dry strips must be rehydrated (usually overnight) to their 
original thickness of 0.5mm with a rehydration buffer containing either 8M urea or 
2M thiourea and 6M urea, 0.5-4% non-ionic or zwitterionic detergents (e.g. 2% 
CHAPS), a reductant (typically 0.4% DTT) and 0.5% vlv CA (e.g. IPG buffer or 
Phannalyte 3-10). IPG dry strips are either rehydrated with the sample already 
dissolved in rehydration buffer (sample in-gel rehydration), or with rehydration 
buffer without sample, followed by sample application by cup-loading. For sampIe 
in-gel rehydration (Rabilloud et al., 1994), the sample (1-lOmg proteinlml) is 
directly solubilised in a defined volume of rehydration buffer. Sample in-gel 
rehydration is not recommended for samples containing very high M,, very alkaline 
andlor very hydrophobic proteins since these are taken up into the gel only with 
difficulty. For cup-loading, the IPG dry strips are reswollen in rehydration buffer 
without sample. After IPG strip rehydration, samples dissolved in lysis buffer are 
applied into disposable plastic cups placed onto the surface of the IPG strip. Best 
results are obtained when the samples are applied at the pH extremes. 
The choice of pH gradient primarily depends on the complexity of the sample. 
Wide or medium range IPGs such a IPGs 3-12,4-9, or 4-7, are typically used to 
analyze simple proteomes or to get an overview of a more complex proteome. 
Settings are usually limited to 50pA per IPG stip and 150V to avoid the protein 
denaturing effects caused by Joule heating, because conductivity is initially high 
due to salts. As the run proceeds, the salt ion migrate to the electrodes, resulting in 
decreased conductivity and allowing high voltages to be applied 
1.3.3 Equilibration of IPG gel strips 
Following isoelectric focusing, IPG strips are equilibrated to further denature 
proteins, maintain solubility and establish an appropriate pH for the second 
dimension SDS-PAGE analysis. Due to the observation that the focused proteins 
bind more strongly to the fixed charged groups of the IPG gel matrix than to CA 
gels, relatively long equilibration times (10-15 min), as well as urea and glycerol to 
reduce electroendosmotic effects are required to improve protein transfer from the 
first to the second dimension (Gorg et al., 1988). Traditionally the best protocol is 
to incubate the IPG strips for 10-15mins with 50mM Tris-HCL (pH 8.8), containing 
2% W/V SDS, 1% W/V DTT, 6M urea and 30% w/v glycerol followed by a fhther 
10-1 5 minute equilibration in the same solution containing 4% (w/v) iodacetamide 
instead of DTT (Gorg et aL, 1988). The latter step is used to alkylate any free DTT, 
as otherwise it migrates through the second-simension SDS-PAGE gel, resulting in 
an artefact known as point streaking that can be observed after silver staining (Gorg 
et al., 1995). More importantly, the iodacetamide alkylates sulfhydryl groups and 
prevents their reoxidation; this s t 6  is highly recommended for subsequent spot 
identification by MS. After equilibration, the IPG strips are applied onto the surface 
of the second-dimensional SDS-PAGE gel. 
1.3.4 Second dimension: SDS-PAGE 
SDS-PAGE can be performed on horizontal or vertical systems (Gorg et al., 1995). 
Horizontal setups are ideally suited for ready-made gels (e.g. ExcelGelSDS; GE 
Healthcare), whereas vertical systems are preferred for multiple runs in parallel, in 
particular for large-scale proteome analysis which usually requires simultaneous 
electrophoresis of batches of second-dimension SDS-PAGE gels for higher 
through-put and maximal reproducibility (Anderson et al., 1978). The most 
commonly used buffer for the second dimension of 2-DE is the discontinous buffer 
system of Laemmli (Laemmli et al., 1970). The analysis of low M, (45kDa) and 
high M, (15OkDa) proteins is somewhat intricate since there is no standard 2-DE 
system which effectively allows separation of proteins over the entire M, range 
between 5kDa and 5OOkDa. A common approach is to combine several gels 
optimised for the appropriate M, ranges 5-30kDa, 15-200kDa and >150kDa. 
Protein detection and quantitation 
After 2-DE, the separated proteins have to be visualised, either by universal or by 
specific staining methods. Concentrations of individual proteins in a single cell 
differ between six or seven orders of magnitude, ranging from several millions of 
copies/cell for some highly abundant proteins to a few copies/cell for low abundant 
proteins. These enormous variations in protein concentrations are a major challenge 
for almost all currently available protein detection methods (Corthals et al., 2000). 
The most important properties of protein visualisation methods are high sensitivity, 
high dynamic range, reproducibility and compatibility with post-electrophoretic 
protein identification procedures such as MS. Universal detection methods of 
proteins on 2-D gels include staining with anionic dyes (e.g. Coomassie Blue), 
negative staining with metal cations (e.g. zinc imidazole), Silver-staining, 
fluorescence staining or labelling, and radioactive isotopes, using autoradiography , 
fluorography, or Phosphor-imaging. For most of these staining procedures, the 
resolved polypeptides have to be fixed in solutions such as ethanol/acetic acid/HzO 
for at least several hours before staining to remove any compounds (e.g. CA 
detergents) that might interfere with detection. Specific staining methods for 
detection of Post-Translational Modification (PTM) (glycosylation, 
phosphorylation etc.) are employed either directly in the 2-DE gel or more 
frequently after transfer (blotting) onto an immobilised membrane. The blotted 
proteins can be probed with specific antibodies or with lectins. 
1.4.1 Universal protein detection and quantitation methods 
Countless staining procedures have been reported in the literature ever since the 
pioneering work of Omstein and Davis (Omstein et al., 1964; Davis et al., 1964) 
established a high resolution zone electrophoretic method in polyacrylamide gels, 
called disc-electrophoresis on account of several discontinuities established along 
the migration path for sharpening the analyte zones. They can be roughly divided 
into the following categories: (1) organic dyes; (2) silver stains; (3) negative 
stainsfreverse staining; (4) fluorescent stains. 
The Coomassie stains (organic dyes) involve dye-dye interactions among 
Coomassie dyes that are ionically bound to, or in hydrophobic association with 
protein molecules (Wilson et al., 1979) Colloidal Brilliant Blue (CBB) staining 
methods have found widespread used for the detection of proteins on 2-DE gels, 
because of their low price, ease of use and compatibility with most subsequent 
protein analysis and characterisation methods such as MS. The limitation of CBB 
stains lies in their insufficient sensitivity (detection limit in the range of 200-500ng 
protein per spot), which does not permit the detection of low abundance proteins. 
Reverse staining exploits the fact that protein-bound metal cations (e.g. zinc, copper 
or potassium) are usually less reactive than the .free salt in the gel. Thus, the speed 
of precipitation of free or only weakly bound ions to form an insoluble salt is 
slower on sites occupied by proteins than in the protein-.free background. This 
generates transparent protein zones or spots while the gel background becomes 
opaque due to the precipitated, unsoluble salt. The advantages of reverse staining is 
they act rapidly (15mins for most applications) and allow easy recovery of proteins 
from gel matrices, since they do not require a fixation step. The zinc stain method is 
quick and is more sensitive than CBB (Adams et al., 1990). The detection limit is 
20-50ng of protein per spot and is compatible with subsequent protein identification 
by MS. The major disadvantage of zinc staining is its restricted linear dynamic 
range making this staining method unsuitable for detecting quantitative differences 
on 2-DE gels. 
Silver staining methods (Menil et aL, 1981) are far more sensitive than CBB or 
zinc stains. Silver staining is reported to increase the sensitivity of protein detection 
over Coomassie Blue staining by 2000-fold, from tenths of a microgram to tenths of 
a nanogram (Merril et al., 1981). All silver stain protocols depend on the reduction 
of ionic to metallic silver onto the protein surface. Although silver staining is 
decidedly the most sensitive stain, silvering protocols are highly erratic due to a 
number of parameters such as temperature, quality of solvents, developing times. 
Moreover, a large number of silvering techniques do not allow for further 
processing of proteins since aldehydes irreversibly cross-link polypeptide chains, 
although aldehyde-free silver protocols are available, albeit with lower sensitivities 
(Sinha et al., 2001). 
Better and more reproducible results in terms of sensitivity and linear dynamic 
range of detection are obtained by protein detection methods relying on fluorescent 
compounds or radiolabelling of proteins combined with highly sensitive electronic 
detection methods. Prior to the advent of highly sensitive silver staining, detection 
of proteins labelled with radioisotopes was the only method of sensitive detection 
for proteins separated on 2-DE gels. Radiolabelling can be accomplished by 
incorporating radioactive isotopes in proteins. In vivo metabolic radiolabelling of 
samples by the incorporation of radioactive amino has been extensively used for 
proteome analysis of microorganisms and cell culture systems. The radiolabelled 2- 
DE separated proteins can be detected by autoradiography of fluorography using X- 
ray films which are exposed to the dried gels and which can be quantified by 
densitometry. However, these film based techniques require long exposure times 
(up to several weeks) if high sensitivity is desired. To overcome the limitations of 
X-ray film-based autoradiography, several electronic methods for the detection of 
radiolabelled proteins in 2-D gels have been developed e.g. phosphor-imaging. The 
advantages are the possibility to detect very low levels of radioactivity in a 
considerably shorter time and the higher dynamic range (up to five orders of 
magnitude) (Patterson et al., 1993). The major disadvantages of radiolabelling 
technology are the well known general shortcomings associated with radiolabelling, 
such as hazardous and expensive radiochemicals, waste disposal, safety 
considerations and the high costs for equipment (phosphor-imager, imaging 
screens). 
Due to the shortcomings of organic dyes, silver staining or radiolabelling for 
visualisation and quantitation of proteins, fluorescent detection of proteins has 
gained popularity for proteome analysis. The best known example of pre- 
electrophoretic fluorescent labels is the flourophore monobromobirnane (Urwin et 
al., 1993) and the cyanine-based dyes (Unlu et al., 1997) that react with cysteine 
and lysine residues, respectively. The latter dyes are commercially available as 
CyDyes (GE Healthcare). The major problem of pre-electrophoretic labelling is the 
occurrence of protein size and/or protein charge modifications which may result in 
altered protein mobilities alongside the M, andlor pZ axis. Alternatively, proteins 
can be stained with a fluorescent dye molecule after the electrophoretic separation 
has been completed. The most prominent example is the ruthenium-based dye 
SYPRO Ruby (Berggren et al., 2002). Staining is accomplished within a few hours 
in a single step procedure which may be easily adapted for use with automated 
instrumentation. The detection limit is approximately 1 -2ng proteidspot, and the 
linear dynamic range of quantitation is about three orders of magnitude. A cost 
effective alternative to SYPRO Ruby staining, which is based on Ruthenium II tris 
(bathophenanthroline disulfonate) has been developed by Rabilloud et al., (2001). 
In conclusion, protein detection and quantitation methods based on fluorescent 
staining andlor labelling are rather promising. They have a comparatively wide 
linear dynamic range (>I 03) and are relatively easy to use. Furthermore, most 
fluorescent staining procedures are compatible with subsequent protein 
identification methods such as MS. The major limitation of most fluorescent 
staining methods is their lowered sensitivity compared to electronic detection 
methods of radiolabelled proteins. Typically, only proteins expressed at greater than 
lo3 copies/cell can be detected on a standard 2-DE gels by using fluorescent dye 
technologies, whereas at least in theory less than a dozen copies of a proteidcell 
can be visualised with the most sensitive electronic detection methods for 
radiolabelled proteins. 
Methods for the analysis of protein (Post Translational 
Modifications) PTMs 
Through genome sequencing no information can be gained on post-translational 
modifications PTMs of proteins. PTM is when the primary structure of the protein 
is altered after the protein has been translated and is already folded. Proteins can 
display a broad range of PTMs, the most common of which are summarised in table 
1.1. These modifications act on individual residues either by cleavage at specific 
points, deletions, additions or having side chains converted or modified. 
The main post-translational modifications associated with proteins 
Acetylation, acylation, ADP-ribosylation 
Amidation 
y-Carboxylation an P-hydroxylation 
Disulfide bond formation 
Glywsylation 
Phosphorylation 
Proteolytic processing 
Sulfation 
Table 1.1 The main post-translational modifications associated with proteins 
Protein phosphorylation is a key PTMs crucial in the control of numerous 
regulatory pathways, enzyme activites and degradation of proteins, whereas 
glycosylation is associated with biochemical alterations, developmental changes 
and pathogenesis, e.g. tumorgenesis. Hence detection and characterisation of PTMs 
are a major task in proteomics. Phosphorylation results in a shift of the protein pZ to 
more acidic values. One of the strengths of 2-DE is its capability to readily locate 
post-translationally modified proteins, as they frequently appear as distinct rows of 
spots in the horizontal andlor vertical axis of the 2-DE gel. 
Phosphoproteins can be detected on 2-DE gels by autoradiography of phosphor- 
imaging after in-vivo incorporation of s ' ~  or orthophosphates into proteins. An 
alternative method for phosphoprotein detection is immunostaining with 
phosphoamino acid-specific poly- or monoclonal antibodies after transfer of the 2- 
DE separated proteins onto an immobilising membrane. Fluorescent detection of 
phosphoproteins separated on 2-DE using Pro-Q Diamond phosphoprotein dye 
(Molecular Probes) which are MS compatible is also possible. Phosphoserine-, 
phosphothreonine-, and phosphotyrosine- containing proteins can be detected using 
Pro-Q Diamond (Steinberg et al., 2003). The detection limit is 1-2ng. However the 
specificity of the stain, in particular with complex protein samples has been 
questioned since highly abundant, non-phosphorylated proteins may also be 
stained, albeit less intense than the phosphorylated ones. 
The most classical procedure for glycoprotein staining is periodic acid-Schiff 
(PAS). When treated with periodic acid, vicinal diols are oxidised to aldehydes, 
able to react with pararosaniline, a triphenylmethane derivative, and to sodium 
metabisulfite (together, the Schiff s reagent) and to form an adduct, pink to 
magenta in colour. The procedure has been adapted to glycoprotein detection in 
gels (Zacharius et al., 1969). The sensitivity is low, 25-100ng carbohydrate or l- 
10p highly glycosylated protein. Recently, Pro-Q emerald 488, a glycoprotein stain 
that reacts with periodic acid oxidised carbohydrate groups and which generates a 
green fluorescent signal on glycoproteins has been described (Hart et al., 2003). 
This stain permits detection of 5-20ng of glycoprotein per spot, depending on the 
nature and degree of glycoprotein glycosylation. The second principle for 
glycoprotein detection is based on sugar binding proteins so-called lectins. A wide 
range of lectins with different carbohydrate specificities are commercially 
available. However for the detailed analysis of the saccharide composition of 
glycoproteins, HPLC or MS-based methods are usually preferred. 
1.6 Difference In-Gel Electrophoresis (DIGE) 
A bottleneck for high throughput proteomic studies is image analysis. In 
conventional 2-D methodology, protein samples are separated on individual gels, 
stained and quantified, followed by image comparison with computer aided image 
analysis programs. Because multistep 2-DE technology often prohibits different 
images fiom being perfectly superimposed, image analysis is frequently very time 
consuming. To shorten this laborious procedure ~ n l i i  et al., (1997) have developed 
a method called DIGE, in which samples are labelled in vitro using different 
fluorescent cyanine minimal dyes (GE Healthcare) differing in their excitation and 
emission wavelengths. Three CyDyes are commonly used, namely Cy2, Cy3 and 
Cy5, which allow labelling of two samples of proteins plus an internal standard 
(Alban et al., 2003). This internal standard, typically a pooled mixture of all the 
samples in the experiment is used for normalisation of data between gels thereby 
minimising experimental variation and increasing the confidence in matching and 
quantitation of different gels in complex experimental designs. These different 
fluorescent cyanine minimal dyes differ in their excitation and emission 
wavelengths and are mixed with sample prior to IEF and separation on a single 2D 
gel. After consecutive excitation with all three wavelengths, the images are overlaid 
and subtracted (normalised), whereby only differences (e.g. up- or down regulated, 
and/or PTM proteins) between the samples are visualised. Due to the comigration 
of the sample, methodological variations in spot positions and protein abundance 
are excluded and consequently image analysis is facilitated considerably. 
Nevertheless, this approach is still dependent on accurate matching and comparison 
of large sets of 2-DE gels in order to generate meaningful data on differential 
protein expression between sets of samples (Dowsey et aL, 2003). Applications 
that profit from DIGE include samples generated under various pre specified 
conditions, the comparison of extracts and the analysis of biological variance. 
The pIs of the cyanine dye labelled proteins remain unaffected, because the cyanine 
dyes compensate for the loss of the positive charge of the lysine residues. However, 
the M, increases by 434-464 Da (depending on the dye molecule) per labelled 
lysine residue. Consequently, labelling of more than one lysine reside per protein 
molecule must be avoided otherwise labelling with CyDyes would result in 
multiple spots in the vertical axis of the 2-DE gel. In practice, approximately 3-5% 
of protein is labelled (referred as minimal labelling). Since the bulk of the protein 
remains unaltered, the slight increase in M, sometimes presents a problem for spot 
excision for MS analysis, particularly with lower M, proteins (Shaw et al., 2003). 
This off-set has to be taken into account when automatic spot pickers are used. One 
alternative is to stain the separated proteins additionally with SYPRO Ruby or CBB 
prior to spot picking fiom microperparative gels. Another is so-called saturation 
labelling with similar cyanine dyes with label cysteine (instead of lysine) residues 
to saturation (Shaw et al., 2003). An additional advantage of saturation is the 
greater sensitivity of the stain with a detection limit of approximately O.lng of 
protein compared to lng with minimal labelling Van den Bergh et al., (2004). 
Saturation labelling has several drawbacks, (1) the labelling reaction must be 
carried out at a defined proteiddye ration to obtain an optimal 2-DE spot pattern 
with a minimal number of spot trains in the vertical dimension, (2) the dye ratio 
must be assessed for different types of samples, depending on the percentage of 
cysteines, (3) care must be taken to avoid side-chain reactions, such as lysine 
labelling, (4) up to 25% of the protein material may precipitate during the labelling 
reaction due to the introduction of the hydrophobic dye molecule and (5) the 2-DE 
spot pattern is significantly altered compared to that of unlabelled or minimal- 
labelled proteins (Shaw et al., 2003). 
Computerised 2-D image analysis 
One of the key objectives of proteomics is to identify the differential expression 
between control and experimental samples run on a series of 2-D gels. That is, the 
protein spots that have been inhibited, induced or have changed abundance 
(increased or decreased in size and intensity). Once these gel features have been 
found, the proteins of interest can be identified using MS. This goal is usually 
accomplished with the help of computerised image analysis systems @owsey et al., 
2003). The first step in computerised image analysis of 2-DE protein patterns is 
capture of the gel image in a digital format. A range of devices, including modified 
document scanners, laser densitometers, CCD cameras, and fluorescent scanners, 
phosphor imagers are available for the acquisition of 2-D gel images. The saved 
images are then subjected to computer assisted image analysis. The traditional 
workflow for 2-DE software package is (1) preprocessing of the gel images i.e. 
normalisation, cropping and background subtraction, (2) spot segmentation, 
detection and expression quantification, (3) landmarking i.e. an initial user guided 
pairing of a few spots between the reference and sample gels. The sample gel is 
warped to align the landmarks, (4) matching i.e. automatic pairing of the rest of the 
spots, (5) identification of differentially expressed spots and (6) data presentation 
and interpretation (Dunn et al., 1992). Currently, several 2-D image analysis 
software packages are commercially available (Progenesis Samespot-Nonlinear 
Dynamics; D~C~~P-GE Healthcare). These programs have been continuously 
improved and enhanced over the years in terms of faster matching algorithms with 
lesser manual intervention, and with focus on automation and better integration of 
data from various sources. The digitised image is first subjected to several clean up 
steps to reduce background smear and to remove horizontal andfor vertical streaks. 
This procedure is usually fast and does not require much user interaction. The 
individual spots on the 2-D pattern are then detected and quantified. This step is 
also performed automatically. Regrettably, most image analysis programs do not 
identify all spots correctly, particularly when the overall quality of the 
electrophoretic separation is low (e.g. when crowded areas and overlapping spots 
due to improper sample preparation or insufficient spatial resolution are present on 
the gel). Hence, manual spot editing with reference to the original stained.2-DE gel 
(or image) is usually necessary. Depending on the number of spots, quality ofithe 2- 
DE separation and the algorithms used for spot detection, this process may be quite 
laborious and time-consuming. After spot editing, each spot on one 2-DE gel must 
be matched by means of a reference (master) gel. For this, in most computer aided 
2-D image analysis programs, several landmark spots (which should be evenly 
distributed over the entire gel) must be manually identified by the operator. Starting 
from these landmark spots, the program proceeds to match the other spots 
automatically. Again, mismatches must be carefully checked and edited manually. 
Typically, at least two 2-D gel patterns are matched (e.g. control versus disease) 
and then compared to each other with respect to qualitative and quantitiative 
differences between the 2-D patterns. 
1.8 Protein Identification 
MS has become the technique of choice for identification of proteins from excised 
2-D gel spots. Despite the outstanding properties and widespread application of 2- 
DE, almost 20 years went by before systematic use of 2D PAGE gels became an 
integral part of the revived field now termed proteomics. 2D PAGE gels were far 
ahead of their time because no method was available for the rapid, routine 
identification of the protein spots on the gels. In the past decade, two crucial 
developments have changed the situation. First, whole genome sequencing for an 
increasing number of organisms has defined at the gene level all proteins that exist 
in that organism. This has meant that, rather than a complete covalent 
characterization being necessary to identify a protein, partial information on 
fragments or sequence is adequate to identify the protein at the gene level within a 
genome sequence database. Second, mass spectrometric methods, largely based on 
MALDI-TOF andlor electrospray ionization with subsequent fragmentation of 
peptides, can now supply the needed information to identify the protein at 
sensitivities routinely below 1 pM (Cafias et al., 2006). Two mass spectrometric 
methods for rapid identification of proteins at the gene level with samples of the 
amounts readily available on 2D gels are now in widespread use. One of these 
methods uses the characteristic distribution of peptide masses obtained by 
enzymatic fragmentation of proteins (Henzel et al., 1993). A number of computer 
programs are available for using the observed peptide masses to search gene 
sequence databases for proteins that fit the mass fingerprint (Henzel et al., 1993, 
Yates et al., 1993; Clauser et al., 1995; Wilkins et al., 1997). The other method for 
protein identification uses sequence tags (Mann & Wilm, 1994; Mann, 1996); i.e., 
partial amino acid sequence information. Searching of gene sequence databases is 
again used to identify the protein at the gene level. 
Mass spectrometric measurements are carried out in the gas phase on ionised 
analytes. By definition, a mass spectrometer consists of an ion source, a mass 
analyser that measures the mass-to-charge ratio (dz) on the ionised analytes and a 
detector that registers the number of ions at each mlz value. Matrix-assisted laser 
desorption ionisation (MALDI) and electrospray ionisation (ESI) are the two 
techniques most commonly used to volatise and ionise the proteins or peptides for 
mass spectrometric analysis. MALDI sublimates and ionises the samples out of a 
dry, crystalline matrix via laser pulses. MALDI-MS is normally used to analyse 
relatively simple peptide mixtures. ESI ionises the analytes out of a solution and is 
therefore readily couple to a liquid-based separation tools. Integrated liquid- 
chromatography ESI-MS systems (LC-MS) are generally preferred for the analysis 
of complex samples. 
The mass analyser is central to the technology. In the context of proteomics, its key 
parameters are sensitivity, resolution, mass accuracy and the ability to generate 
information-rich ion mass accuracy spectra from peptide fragments. There are four 
basic types of mass analyser currently in proteomics research. These are time of 
flight (TOF), ion trap, quadmpole and Fourier transform ion cyclotron (FR-MS) 
analysers. They are very different in design and performance, each with its own 
strength and weakness. 
1.8.1 Matrix Assisted Laser Desorption Ionisation (MALDI) - Time of Flight 
Crov 
The matrix assister laser desorptionlionisation technique was developed in 1987 
(Karas et al., 1987) and has increased the upper mass limit of mass spectrometric 
analyses of large biomolecules to over 300,000Da. It has also enabled the analyses 
of biomolecules by mass spectrometry to become easier and more sensitive. The 
time-of-flight (TOP) mass spectrometer operates on the principle that when a 
temporally and spacially well defined group of ions of differing masslcharge ( d z )  
ratios are subjected to the same electric field and allowed to drift in a region of 
constant electric field, they will traverse this region in a time which depends on 
their m/z ratios. Reflectron MS offers improves mass resolution by compensating 
for the difference in flight times of the same d z  ions of slightly different kinetic 
energies by means of an ion reflector. This results in focusing the ion packets in 
space and time at the detector. 
The carbon, hydrogen, nitrogen, oxygen, and sulphur in proteins, as elsewhere, are 
13 . mixtures of isotopes. About one carbon atom in 90 is C instead of the usual "c, 
so a peptide with a mass of 1900, containing about 90 carbon atoms, will on 
average contain one 13C atom, but may contain none, one, two, or more. Thus such 
a peptide will not give a single sharp peak, but a multiplet, as observed in Figure 
1.1 which is the autodigestion trypsin 111 peak fkom a typical MALDI-TOF MS 
spectrum of a protein digested with trypsin. 
Figure 1.1 MALDI ToF analysis of a single Charge Trypsin peak at 2211.104mlz 
The first peak seen in the cluster is the monoisotopic peak consisting of the most 
common basic element isotopes ("c). The area under the peaks is proportional to 
the statistical chance of having a molecule with 0,1,2, or more13c atoms. 
The difference between the isotopes shows the charge state of the ion. As shown in 
the spectrum above, if the m/z difference is one atomic mass unit then the charge is 
+l. A charge of +2 would give an m/z difference of 0.5, however in MALDI mass 
spectrometry this is fairly uncommon. 
One of the most important aspects of MALDI-TOF-MS is the preparation of a good 
sample (Cohen et aL, 1996; Beavis et aL, 1996). Many variables influence the 
integrity of a good homogeneous MALDI sample and may include the 
concentration of matrix and analyte, choice of matrix (see table 1.2), analyte sample 
history (i.e. exposure to salts, strong ionic detergents). 
Matrix 
a-Cyano-4-hydroxycinnamic acid 
(CHCA) 
(sinapinic acid) 
2,50-Dihydroxybenzoic acid (DHB) 
1 
Table 1.2 Example of common MALDI maw 
Application 
Peptides, proteins, lipids and 
oligonucleotides 
Peptides, proteins and glycoproteins 
Peptide, proteins, lipids and 
oligoasccarides 
!s at 337nm 
MALDI uses laser pulses to ionise and volatilise proteins and peptides that have 
been embedded in the dry crystalline organic matrix. MALDI is usually coupled to 
TOF analysers that measure the mass of intact peptides, because there is a fixed 
flight distance to the detector and ions with different masses will travel at different 
speeds. Peptide ions with the same m/z will exhibit equal times of flight. The 
acquired spectra by MALDI-TOF mass spectrometry allows mass fingerprinting 
(PMF). PMF is typically the primary tool for protein identification. This technique, 
which is user .friendly and quite fast, based on the finding that a set of peptide 
masses obtained by MS analysis of aprotein digest (usually trypsin) provides a 
characteristic mass fingerprint of that protein. The protein is then identified by 
comparison of the experimental mass fingerprint with the theoretical peptide 
masses generated in silico using protein and nucleotide databases. Because mass 
mapping requires an essentially purified target protein, the technique is commonly 
used in conjunction with 2-DE. This approach proves very effective when trying to 
identify proteins from species whose genomes are relatively small, completely 
sequenced and well annotated. PMF is not so reliable for organisms whose 
genomes have not been completely sequenced. Protein spots kom 2-DE gels 
kequently require concentrating and desalting (salt ions suppress ionisation) prior 
to MALDI MS. The peptides can trapped with Reverse Phase material (ZipTip, 
Millipore), and after desalting washes with water, they can be eluted with 5O%ACN 
containing matrix. The method results in highly purified, salt-eee peptide solutions 
that can be directly applied to MALDI PMF database searching. 
A second problem is to identify proteins that are extensively post-translationally 
modified, since the peptides generated from these proteins may not match with the 
unmodified protein in the database (Graves et al., 1999). A third problem is that 
PMF does not work as well if several different proteins are present in the spot. 
Search engines such as ProFound (Zhang, et al., 2000) have been developed that 
enable identification of the correct protein(s) even when the data quality is 
relatively low or when the sample consists of a simple mixture of proteins. In cases 
proving impossible to identifl by PMF alone it is essential to obtain amino acid 
sequence information. This is most readily accomplished using either MALDI-MS 
with Post Source Decay (PSD) or by MALDI-TOF Instruments capable of 
kagmenting MALDI generated precursor ions e.g. MALDI-TOF-TOF and hybrid 
quadrupole TOF Instruments. 
To allow the kagmentation of MALDI-generated precursor ions, MALDI ion 
sources can be coupled to quadrupole ion-trap mass spectrometers (Krutchinsky et 
al., 2001) and to two types of TOF instruments. In the first, two TOF sections are 
separated by a collision cell (TOF-TOF instrument), whereas in the second, the 
hybrid quadrupole TOF instrument, the collision cell is placed between a 
quadrupole mass filter and a TOF analyser (Loboda, et al ,  2006). 
1.8.2 Ion Trap 
In ion-trap analysers, the ions are first captured or "trapped" for a certain time 
interval and are then subjected to MS or MSMS analysis. Ions created by 
electrospray (ESI) are focused using electrostatic lensing system into the ion trap. 
An electrostatic ion gate pulses open and closed to inject ions into the trap. The 
time during which ions are allowed into the trap, termed the "ionisation period" is 
set to maximise signal while minimising space-charge effects. The ion trap is 
typically filled with helium. Collisions with helium dampens the kinetic energy of 
the ions and serve to quickly contract trajectories toward the center of the ion trap, 
enabling trapping of injected ions. Trapped ions are further focused toward the 
center of the trap through the use of an oscillating potential, called the fundamental 
if, applied to the ring electrode. An ion will be stably trapped depending upon the 
values for the mass and charge of the ion, the size of the ion trap (r), the oscillating 
frequency of the fundamental rf (w), and the amplitude of the voltage on the ring 
electrode (V). Ion traps are robust and sensitive. The linear or two-dimensional ion 
trap (Hager et al., 2003 and Schwartz et al., 2002) are recent developments where 
ions are stored in a cylindrical volume that is considerably larger than that of the 
traditional, three dimensional ion traps allowing increased sensitivity, resolution 
and mass accuracy. 
The Fourier transform ion cyclotron resonance mass spectrometer (FTICR-MS) 
instnunent is also a trapping mass spectrometer. They measure mass indirectly by 
oscillating ions in a strong magnetic field. Because these ions will oscillate as a 
function of their d z ,  measuring the ffequency of these oscillations allows inference 
of d z  using a Fourier transform (FT). These instruments provide the highest 
combination of mass accuracy, resolution and intrascan dynamic range (Khalsa- 
Moyers et al., 2006). They offer the highest resolution performance and is the most 
potential protein analyser for protein characterisation and analysis of PTM. Its 
strengths are high sensitivity, mass accuracy, resolution and dynamic range (Martin 
et al., 2005). In spite of the enormous potential, the expense of FTIR-MS 
instruments has limited their routine use in pmteomics research. The instruments 
are expensive, need permanent special experience with high-field magnets, their 
capacity is still limited, and hence only special analyses can be performed and high 
throughput seems not be feasible at present (Wittmann-Liebold et al., 2006). 
Recently Orbitrap Mass Analysers can deliver accurate mass and high resolution 
similar to those achievable with FT-MS instnunentation but are more affordable 
and have less running costs to the latter (Hardman et al., 2003). Orbitrap is an ion 
trap where the ions are trapped in an electrostatic field (Hardman et al., 2003). A 
Fourier Transform is employed to obtain oscillation ffequencies for ions with 
different masses resulting in an accurate reading of their m/z. 
Electropray Ionisation has mostly been coupled to ion traps and used to generate 
ftagment ion spectra (collision-induced (CID) spectra) of selected precursor ions 
(Albersold et al., 2001). 
1.8.3 Tandem Mass Spectrometry 
A Tandem mass spectrometry (MSIMS) consists of two mass analysers separated 
by an ion-activation device. This makes it possible to separate an ion of interest 
using the first analyser, induce the ion to dissociate by activation and then analyse 
the dissociation products in the second analyser. These dissociation products 
provide a "structural fingerprint" for $at particular ion and thereby provide detailed 
structural information (e.g. amino acid sequence on it). The sequencing of peptides 
and proteins by various ion-sequencing techniques has been demonstrated, 
including low- and high energy collision -induced dissociation (CID) (Hunt et al., 
1996), surface-induced activation (SID) (Biemann et aL, 1988) and photoinduced 
dissociation (PID) (Beussman et al., 1995). Currently, the most comrnonlyused 
ion-activation technique for the dissociation of peptide ions is low-energy CID 
(which involves the collision of peptide ions at low speeds with an inert gas). The 
fragment ions produced upon peptide-ion activation are analysed by a second mass 
analyser. Under these low energy gas phase collision conditions, peptide ions 
mostly fragment at the amide (peptide) bonds along the backbone, generating a 
ladder of sequence ions. There are three different types of bonds that can fragment 
along the amino acid backbone: the NH-CH, CH-CO and CO-NH bonds. Each 
bond breakage gives rise to two species, one neutral and the other one charged, and 
only the charged species is monitored by the mass spectrometer. The charge can 
stay on either of the two fragments depending on the chemistry and relative proton 
affinity of the two species. Hence there are six possible fragment ions for each 
amino acid residue and these are labelled in Figure 1.2, with the a, b, and c ions 
having the charge retained on the N-terminal fragment and the x, y, z ions having 
the charge retained on the C-terminal fragment. The most common cleavage sites 
are at the CO-NH bonds which give rise to the b andlor the y ions (Figure 1.2). The 
mass difference between two adjacent b ions, or y ions is indicative of a particular 
amino acid residue (Biemann et al., 1990) (see table 1.3). 
Immonium ions (labelled "i" appear in the very low d z  range of the MS-MS 
spectrum. Each amino acid residue leads to a diagnostic immonium ion, with the 
exception of the two pairs leucine (L) and iso-leucine (I), and lysine (K) and 
glutamine (Q), which produce immonium ions with the same d z  ratio, i.e. d z  86 
for I and L, d z  101 for K and Q. The immonium ions are use l l  for detecting and 
confirming many of the amino acid residues in a peptide, although no information 
regarding the position of these amino acid residues in the peptide sequence can be 
ascertained from the immonium ions. 
Bz - B, = amino acid 
b ion y ion 
Figure 1.2 Example of an amino acid backbone showing where the six possible fragments ions 
could be produced labelled as A, B, C ions having the charge retained on the N-terminal 
fragement and X, Y, Zions having the charge retain on the C-terminal fragment. The mass 
difference between two adjacent b or y ions is indicative of a particular amino acid. Also, an 
example of the most common cleavage site producing b and y ions. 
Letter 
G 
A 
S 
P 
I I 
Name 
Glycine 
Alanine 
Serine 
Proline 
V 
T 
C 
I 
L 
I I 
D I aspartic acid 1 115.03 
Mass, Da 
57.02 
71.04 
87.03 
97.05 
N 
Valine 
Threonine 
Cysteine 
Isoleucine 
Leucine 
99.07 
101.05 
103.01 
113.08 
113.08 
Asparagines 
I I 
114.04 
Q 
I I 
K ( Lysine 
I I 
Glutarnine 
128.09 
E 
H 
F 
128.06 
Y 
W 
glutamic acid 
Histidine 
Phenylalanine 
carboxymethyl cysteine 
129.04 
137.06 
147.07 
Tyrosine 
Tryptophan 
161.05 
I I 
I I I I 
Table19 The amino acids and their respective Masses @a). 
163.06 
186.08 
carbamidated cysteine 
I I 
160.03 
oxidised methionine 147.04 
An example of an MSNS product ions is illustrated in Figure 1.3. The molecular 
mass of the peptide was measured using the LTQ Linear Ion Trap in Full MS mode 
and found to be 667.6Da, the dominant ions in the MS spectrum being the protonated 
molecular ions ( M + H ~  at m/z 668.6. These ions were selected for transmission 
through the first analyser to produce a MSIMS spectrum. The sequence (amino acid 
backbone) ions have been identified, the peptide fragmented predominantly at the 
I GO-NH bonds and have both b and y ions. The b series ions are labelled with red 
vertical lines and the y series have been labelled with blue vertical lines. The mass 
difference between adjacent members of a series can be calculated e.g. y8 - y7 = 
860.5 - 713.5 = 147 Da which is equivalent to a Phenylalanine (F) residue; and 
sirnilarily b9 - b8 = 1005.6 - 908.5 = 97.1 Da which is equivalent to Proline (P) 
residue. In this way, using either the b series or the y series (y series reads from right 
to left and b from left to right), the amino acid sequence of the peptide can be 
determined and was found to be IMNTFSWSPK from the protein Beta Tubulii. 
Figure 1.3 MSIMS product ion spectrum using the LTQ Linear Ion Trap after fragmentation of 
a peptide taken from a tryptically digested protein. 
1.9 Combining liquid chromatography with mass spectrometry using ESI 
Mass spectrometry is inherently well-suited for mixture analysis, and can be further 
augmented by electrospray ionisation, which enables liquid chromatographic 
techniques to be combined with tandem mass spectrometers, making it possible to 
assign structural identity to individual species in a complex mixture by 
chromatographic separation on their chemical properties followed by a separation 
based on masslcharge (mlz) ratios and subsequent structural characterisation in the 
MSMS mode. 
Low flow-rate electrospray (nano-LC-electrospray) can efficiently spray small 
volumes of aqueous solutions using pressure assisted flow rates of 200nl/min with 
fused silica capillaries. For most studies on peptides, the low flow rates used by 
small-bore liquid chromatography (LC) columns offer the greatest sensitivity for 
analysis (Griffin et al., 1991). Consider a 100 femtomole (lo-'' mol) of protein 
isolated fiom a 2-DE gel. For simple analysis by ESI-MSIMS, the typical minimum 
molar concentration must range between 0.1 to 1.0pM. This means that the total 
sample must be contained within a volume no larger than 1 pL as it flows through 
the end of the ESI emitter into the mass spectrometer. A lmm ID microbore 
column, having a typical column volume of 200pL, flowing at 5OpL/min, yields an 
elution volume of approximately 12pL for a fifteen second wide peak. Contrasted 
with a 75pm ID nanobore column, having a typical column volume of 0.5pL 
flowing at 200nL/min which yields an elution volume of approximately 50nL for a 
15 second wide peak. Calculated on a per volume basis, a 75pm ID nanobore 
column yields a relative concentration improvement of over 3,700 fold compared to 
a conventional 3.6mm ID column (Tomer et al., 2001). 
In order to obtain primary structural information for peptides, it is necessary to 
acquire tandem-mass-spectral data on the chromatographic peaks that are eluted 
f?om the microcolumn LC onto the mass spectrometer. Two approaches are 
generally employed to acquire tandem-mass-spectral data for peptides. The first 
approach requires premeasurement of m/z values for all the components of the 
complex mixture, followed by a separate analysis of the same mixture to obtain 
tandem mass spectra. The shortcomings of this approach include high sample 
consumption and a requirement for considerable manual intervention. The second 
approach involved automated data acquisition by computer control of the 
instrument, a process that allows both MS and MSMS data to be acquired in a 
single analysis. 
A typical computer algorithm for the automated acquisition of tandem mass spectra 
would involve the following steps. 
(1) scan a mass analyser to record m/z values of ions entering a mass analyser 
(2) search this mass spectrum for an m/z value based on certain preset guidelines 
(3) select the searched m/z value and subject it to M S M S  conditions that are 
calculated from the m/z value of the selected precursor ion 
(4) acquire tandem mass spectra 
(5) reset the instrument back to step 1 
With these ionization methods mass accuracies below lOppm (O.01Da) for a 
peptide with a mass of 1000 Da can be achieved. 
1.10 De Novo sequencing using MSMS spectra 
It is possible to carry out de nova sequencing using the MSMS spectra as the sole 
reference for deducing the sequence of the peptides they represent. All the 
information necessary to reconstruct a peptide sequence could possibly exist in the 
ions generated, although spectra of high enough quality are relatively rare. The 
advantages of using de nova methods are that they may be used when a reference 
database is simply not available, as in the case of organisms with an as yet 
unsequenced genome. De nova sequencing may also be helpful when attempting to 
identify peptides that have been post-translationally modified (Reinders et al., 
2004), which can prevent mass matching when searching a database. The primary 
challenge in de novo sequencing using MUMS is to identify the type of ion that a 
peak in the spectrum represents. Building the spectrum is straightforward if each y 
ion peak can be confidently identified. Unfortunately often a complete enough set 
of reference ions need to create a full sequence is not always present. This may be 
due to ion suppression or poor signal-to-noise ratio in the spectrum. 
1.11 Database searching to identify proteins 
The peptide data (PMF and partial sequence data) are compared with the entire 
protein database (Swiss-Prot, TrEMBL, NCBI, ExPaSy) or with the deduced 
protein sequences fiom the gene database. The proteomics Tools of the Swiss 
Institiute of Bioinfonnatics (SIB) are dedicated to the analysis of protein sequence, 
structure and 2-DE, thereby all known protein sequences of cells and tissues of 
various organisms are accessible. This search routine enables the unambiguous 
identification of proteins from 2-DE if the protein is known and listed in the 2-DE 
database. If only limited sequence coverage was achieved the protein identification 
becomes less safe. With unknown proteins, the identification may be derived from a 
comparison with homologous sequences from other organisms. If this yields 
ambiguous results more efforts to identify the protein has to be made, e.g. by 
preparing nucleotide probes for the identification of the corresponding gene or by 
complete protein sequence analysis. 
The choice of protein cleavage agent affects the distribution of size of the resulting 
peptide fragment according to the specificity of its cleavage. Trypsin, which 
cleaves after arginine and lysine residues, unless followed by proline (Gattiker, et 
al., 2002), produces peptides ranging from one residue long to theoretically any 
length. PMF is highly used and useful method for protein identification, but the 
lack of access to sequence data from the spectra makes its use in high-throughput 
peptide identification limited as mass is not a powerful enough discriminator when 
searching eukaryotic databases (Shadforth et aL, 2006). The use of MSMS, 
however provides access to sequence data, which can be used to more confidently 
identify peptides. In all variants of MSIMS-based experiment, once the precursor 
ions have been selected, they are subject to collision, thus fragmenting them into a 
range of daughter ions as the amide backbone is broken. For any unique peptide, 
the complete spectrum of daughter ions is also unique. The series of y-ions that 
could be expected represents a chain of increasing d z  from the C-terminus, with 
each ion differing excluding N- and C-tenninal groups at that position as successive 
amide linkages are broken, b-ions are complementary to these on the N-terminal 
side of the peptide ion upon fragmentation. Other ion types may also be created 
through loss of water, NH3, CO or immonium ion formation (Papayannopoulos et 
al., 1992). Searching a protein sequence database with MSIMS spectra proceeds 
initially in a similar manner to PMF, with matches to the precursor ion mass within 
a potentially wide tolerance window being selected from the database. Following 
this, the experimental tandem spectrum is compared to a theoretical spectrum 
generated for each candidate peptide. Various scoring methods are then used to 
judge the validity of each match. The most used and widely known probability- 
based scoring algorithms are MASCOT and SEQUEST. MASCOT uses a 
probability-based scoring algorithm based upon MOWSE (Pappin et al., 2003) 
PMF scoring method, but adapted to incorporate additional information such as 
signal intensity and consecutive fragment heuristics, provided by the tandem mass 
spectrum (Colimge et al., 2003). SEQUEST uses a measure of cross-correlation. 
between the top 500 candidate theoretical spectra, chosen using essentially PMF 
identification and the experimental spectrum (Yates et al., 1995). 
Other methods to identify proteins 
1.12.1 Edman Sequencing 
Sequencing by Edman degradation. The Edman sequencing technique allows the 
unambiguously identification of proteins fiom 2-DE blots. 2-DE gels are blotted 
onto PVDF membranes that are developed with CBB for N-terminal Edman 
sequencing. In the blot procedure glycine and Tris buffers should be replaced by 
sodium borate buffers that result in cleaner Edman degradation cycles. Edman 
degradation takes place in a sequencer that automatically degrades proteins and 
peptides fiom their N-terminal end by a step-wise chemical procedure (Edman, et 
al., 1967). 
The reagent phenylisothiocyanate (PITC) is attached to the N-terminal end group 
of the peptide forming a PTC-peptide, which strongly acidic conditions cleaves off 
the first amino acid as aminoathiazolinone derivative (ATZ-amino acid) fiom the 
remaining peptide. The released amino acid is converted to the more stable 
phenylthiohydantoin (PTH-amino acid). Products are normally separated and 
identified by HPLC in a mirco RP C18 column. Blots are applied to the blot 
reaction cartridge of the sequencer. Peptides or proteins that are prone to be washed 
out during Edman degradation may be successfully sequenced by the addition of 
polymers (e.g Biobrene). 
1.12.2 Internal sequencing 
If the N-terminal amino acid is blocked then Edman degradation results in no 
sequence information. Therefore, it is recommended to perform internal sequencing 
of the protein spot of interest. Internal sequencing can be achieved by several 
different approaches. (1) the protein blot or gel piece is proteolytically digested by 
trypsin, which cleaves after lysines and arginines. The peptide fragments are eluted 
and separated by HPLC and then sequenced in the Edman sequencer; or (2) 
alternatively, the generated peptides are examined by MS. The advantage of the MS 
approach is that the peptide mixture can be applied directly to the MS system. Yet, 
application of Edman N-terminal or internal sequencing is useful, (1) when the 
identity and purification of a selected protein is questionable; (2) for identifying .. . 
protein domains, obtained after limited proteolysis. Edman sequencing allows a 
safe identification of the N-terminal region@) of protein domains in such 
experiments. Edman sequencing is highly valuable also for de novo sequencing of a 
protein if no sequencing information is available in databases or cannot be deduced 
ffom genetic data. 
1.13 Proteomic Automated procedures 
Due to the large number of samples which have to be analysed in high-throughput 
proteomics studies, there is an increasingly urgent need for automated procedures 
(Westermeier et al., 2004). Despite earlier improvements such as the possibility to 
run twelve second dimension SDS gels in parallel, 2-DE has long been a laborious 
and difficult to automate procedure. Only recently, the situation has changed due to 
(1) the availability of ready-made gels (IPG Drystrips) on stable plastic supports, 
(2) the introduction of the IPGphor and similar devices for automated first 
dimensional IEF, (3) DIGE, (4) simplified image comparison and improved 
quantitation due to the possibility of including an internal standard, (5) improved 
algorithms and better computer programs for easier gel image analysis, (6) 
automation of spot excision and protein digestion and (7) high mass resolution and 
high mass accuracy of modern MS. 
1.14 Other proteomic methodologies 
1.14.1 Quantitative Proteomics using isotope-coded a f f i t y  tag @CAT) 
ICAT reagents consist of conjugate molecules containing an affinity tag, an isotope 
tag, and a protein-reactive group such as iodacetamide for attachment to cysteine 
SG groups in proteins. A non-deuterated light (do) and a deuterated heavy (d8) pair 
of ICAT reagents are used to determine the relative levels of proteins, e.g. in a 
complex protein mixture. See figure 1.4 for the chemical structure of the tag used 
for ICAT strategies (image from www.appliedbiosystms.com). 
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brotin tag llnker chaln reactive (heavy or light) eroup 
Figure 1.4 Chemical structure of the tag used for ICAT 
Using labelling with ICAT reagents in combination with 2-DE it is possible to 
differentiate two cell states (Aebersold et aL. 2000). After electrophoresis, the spots 
are excised and treated with trypsin. The &tic peptides are analysed by ESI- 
MS/MS. Those peptides that contain both the nornial mass and the isotope mass are 
derived from proteins that differ in the different situations. Comparison of the 
relative abundance of protonated versus deuterated ICAT peptide conjugates results 
in a mass difference of 8 Da between the two samples, allowing to select proteins 
that are differentially expressed in cancer cells compared with normal (Smolka et 
al., 2001). See Figure 1.5 for an example of a strategy for quantifying differential 
protein expression (image f?om Aebersold et aL, 1999). 
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Figure 1.5 Isotope-coded affinity tag has 3 elements, an afiinity tag (biotin) that is used to 
isolate ICAT-labelled peptides, a linker that can incorporate stable isotopes and a reactive 
group with specificity toward thiol groups (cysteines). The reagent exists in 2 forms, a heavy 
(dB) and light (do). ICAT strategy for quantifying differential protein expression. Two protein 
mixtures representing 2 different cell states are treated with do and d8 ICAT reagents 
respectively. ICAT reagent is covalently attached to each cysteinly residue in every protein. 
Protein mixtures are combined and proteolyzed to peptides. ICAT-labelled peptides are 
isolated by use of the biotin tag. These peptides are separated by microcapillary high- 
performance liquid chromatography. A pair of ICAT-labelled peptides is chemically identical 
and easily visualised because it coelutes. An 8- Da difference is measured by scanning mass 
spectrometer. Ratios of the original amounts of protein from the 2 cell states are strictly 
maintained in the peptide fragments. Relative quantification is determined by the ratio of the 
ion currents for the do and d8 tagged peptide pairs. Every other scan is devoted to 
fragmenting and then recording sequence information for the eluting peptide. 
A second generation of ICAT reagents have been developed such as the cleavable 
reagents (cICAT) and the visible-ICAT reagents (iTRAQ AppliedBiosystems) that 
react with amino-groups and contain isobaric tags with reported and balancer 
groups (Weise et al., 2006). During ClD-MS the reporter is cleaved off the peptide 
and releases an isotope series representing the quantity of a single peptide on 
known mass. This technology can be applied to compare total cell lysates without 
any 2-DE which are digested prior to ESI-MSIMS. It should be noted that 
quantification is limited if (1) the protein occurs in many species, (2) the reaction 
with the reagent tag is not quantitiative and (3) peptides of identical sequence occur 
fiom different proteins in the digest. 
1.14.2 Surface Enhanced Laser Desorption Ionisation (SELDI) -ToF MS 
A strategy for Biomarker discovery is the analysis of peptides and proteins present 
in plasma or blood serum by mass spectrometry. SELDI-ToF technology involves 
incubating samples on chips whose surface is coated with a protein-fractionating 
resin (e.g. C18 or strong cationic exchange). The unbound compounds are washed 
away, the chips are overlaid with an energy-absorbing matrix and finally spectra are 
required using laser ionisation and ToF separation mass spectrometry (Simpkins et 
al., 2005). The resulting peak intensities are supposed to correlate with the 
concentrations of diverse peptides in the sample. Biomarker wizard software can 
analyses the spectral map and detects differentially expressed proteinlpeptides with 
statistical significance. Zhukov et al., (2003) used SELDI to identify lung cancer 
biomarkers. Although SELDI technology is well documented for its ability of rapid 
profiling of minute samples, the ability to identify proteins fiom SELDI remains 
challenging and conventional peptide mapping must be employed. 
Multidimensional Protein Identification 'Fechnology 
(MuDPIT) 
Multidimensional Protein Identification technology MUDPIT) is a non-gel 
approach using multidimensional high-pressure liquid chromatography separation, 
tandem mass spectrometry and database searching (Koller et al., 2002). MudPIT 
allows a rapid and simultaneous separation and identification of and 
peptides in a complex mixture without the need for pre- or post- separation 
labelling which is not possible in 2D electrophoresis, ICAT and iTRAQ (Koller et 
al., 2002). Following protein digestion the peptide fragments are allowed to 
separate in parallel with two-dimensional liquid chromatography using a strong 
cation exchange (SCX) column that separate peptides based on charge, and then by 
a reverse phase (RP) column based on hydrophobicity. The peptides are eluted 
directly into a tandem mass spectrometry for l%agrnentation followed by protein 
identification. One of the major weaknesses of MudPIT is in identifying 
quantitative differences in protein expression across protein mixtures (Washburn et 
al,, 2003). Durr et aL, (2004) observed that two replicate MuDPIT analyses 
produced two sets of protein identifications with -65% overlap. 
1.15 Bromodeoxyuridiie (BrdU) 
BrdU is a thymidine analogue capable of inducing epitheloid morphology and altering 
the expression of neuroendocrine markers in small cell lung carcinoma cell lines 
(Feyes et al., 1991). The ability of BrdU to alter differentiation in neuronal, muscle 
and haematopoietic lineages is also well established (Esumi et al., 1989) (Tapscott et 
al., 1989) and (Yen et al., 1987). BrdU competes with thymidine for incorporation in 
DNA, a property which has led to its widespread use in cell proliferation assays 
(Dolbeare et al., 1996). While it appears that BrdU must be incorporated in DNA in 
order to modulate differentiation (Harding et aL, 1978), relatively little is known 
regarding the mechanism(s) of action involved. There is evidence that in some 
systems altered conformation of the BrdU-containing DNA may affect interactions 
with specific transcription factors, leading to either inhibition or induction of 
differentiation, depending on cell type (Lin et al., 1972). 
DLKP is a poorly differentiated squarnous carcinoma cell line which does not express 
keratin proteins or other epithelial markers such as epithelial-specific antigen or 
desmosomal proteins: despite being of epithelial origins (McBride, et al., 1998). 
DLKP cells may represent a stem cell like cell line of lung epithelial lineage which 
has the potential for both proliferation and differentiation. Also, the cells appear to be 
at a very early stage of differentiation, shown by the lack of expression of the simple 
epithelial keratins 8, 18 and 19, and can theoretically progress towards several 
different phenotypes. Treatment of DLKP with 10pM BrdU significantly altered the 
morphology of the cells (McBride et al., 1999). In this study it was noted that within 4 
days of treatment of DLKP with 10pM BrdU the cells showed an increase in cell 
surface area when compared to untreated cells. There was an approximate 2 fold 
increase in cell size with the cells appearing stretched and flattened. 
We have demonstrated in our laboratory that BrdU treatment of DLKP induces 
differentiation. McBride et a1 (1999) showed immunohistochemically, that treatment 
with 10pM BrdU over 7 days induced Keratin 8 and 18 protein (but with no change in 
keratin mRNA levels). 
Meleady and Clynes (2001) demonstrated that BrdU treatment of DLKP resulted in 
increases of integrin a2 and subunit protein. 
BrdU also alters the adhesive properties of DLKP with an increased adhesion to 
collagen Type IV, laminin, fibronectin and ECM gel (Meleady and Clynes 2001). 
Walsh et a1 (2003) showed significant increased levels of eIF4E following exposure 
of DLKP to BrdU. The treatment also resulted in an increase in phosphorylated 
eIF4E. 
1.16 Aims of Thesis 
Previous work conducted in this laboratory has shown that treatment of the poorly 
differentiated lung cell line DLKP with the differentiation modulating agent BrdU 
caused increased expression of growth and differentiation related proteins. Protein 
expression of cytokeratins 8 and 18 and integrins a 2 and 1 were induced 
following BrdU exposure. No previous studies have been undertaken however, to 
examine global changes in protein profiles in this system. 
The main aims of this thesis were as follows: 
1.  To optimise methods of protein identification from 2D colloidal stained gels 
using MALDI-ToF and nanoLC-Tandem Mass Spectrometry to achieve 
reliable high confidence protein identifications. 
2. To examine the effects of BrdU on DLKP using 2-D DIGE technology for 
statistically significant comparisons of protein abundance using three 
biological replicates. 
3. Using optimised Mass Spectrometry based protein identification methods to 
identify any differentially regulated proteins obtained by 2D-DIGE after BrdU 
exposure on DLKP. 
Materials and Methods 
Water 
Ultrapure water was used in the preparation of all media and solutions. This water was 
purified by reverse osmosis (Millipore Milli-RO 10 Plus) and the further purified using 
the Elga Maxima Life Science to a standard of 18MSUcm resistance. 
2.2 Glassware 
Solutions pertaining to cell culture and maintenance were prepared and stored in sterile 
glass bottles. Bottles (and lids) and all other glassware used for any cell-related work 
were prepared as follows: all glassware and lids were soaked in a 2% (vlv) solution of 
RBS-25 (AGB Scientific) for at least 1 hour. This is a de-proteinising agent which 
removes proteinaceous materials from glassware. Following scrubbing and several 
rinses in tap water was then washed by machine using Neodisher GK (Dr.Weigert) 
detergent, an organic, phosphate-based acid detergent. Glassware was then rinsed twice 
with ultrapure water and sterilised by autoclaving. 
2.3 Sterilisation 
Water, glassware and all thermostable solutions were sterilised by autoclaving at 121°C 
for 20 minutes (rnin) under pressure of 15psi. Thermolabile solutions were filtered 
through 0.22pm sterile filters @idlipore, Millex SLGV-25BS). 
2.4 Basal Media preparation 
Medium was routinely prepared and sterility checked by Joe Carey in the NICB. The 
basal media used during routine cell culture were prepared according to the 
formulations shown in Table 2.1 lox media were added to sterile ultrapure water, 
buffered with HEPES and Na2HC03 and adjusted to a pH of 7.45-7.55 using sterile 
1.5M NaOH and 1.5M HCL. The media was then filtered through sterile 0.22pm bell 
filters (PALL 121-58), given a three month expiry date and stored in 500ml sterile 
bottles at 4'C. Sterility checks were carried out on each 500ml bottle of medium as 
described in Section 2.5.5. 
Prior to use, 100ml aliquots of basal media were supplemented with 2mM L-glutamine 
(Gibco 25030-024) and 5% foetal calf serum (FCS) (Gibco) and this was used as 
routine culture medium. This was stored for up to 2 weeks at 4OC, after which time, 
fresh culture medium was prepared. 
Table 2.1 Preparation of basal media 
Mixture F-1-12 Ham with L-Glutamineand 
* HEPES = N-(2-Hydroxyethy1)piperazine-N'-(2-ethanedfonic acid) 
Dulbecco's Modified Eagle Medium Nutrient Mixture F-12 Ham was supplemented 
with 5% FCS. 
2.5 Cell Lines 
All cell culture was carried out in a class I1 down-flow re-circulation laminar flow 
cabinet (Nuaire Biological Cabinet) and any work which involved toxic compounds 
was carried out in a cytoguard (Holten). Strict aseptic techniques were adhered to at all 
times. The laminar cabinet was swabbed with 70% industrial methylated spirits (IMS) 
before and after use, as were all items used in the cabinet. Each cell line was assigned 
specific media and waste bottles and only one cell line was worked with at a time in 
the cabinet which was allowed to clear for 15min between different cell lines. The 
cabinet itself was cleaned each week with industrial detergents (Virkon, Antec, 
International; TEGO, TH.Goldschmidt Ltd.), as were the incubators. 
The cell lines used during the course of this study, their sources and basal media 
requirements are listed in Table 2.5.1. Cell lines were maintained in 75 cm2 flasks non- 
vented (Costar;3075) and 175 cm2 flasks non-vented (NUNC;156502) 
2.5.1. Subculture of Adherent Lines 
During routine subculturing or harvesting of adherent lines, cells were removed from 
their flasks by enzymatic detachment. 
Waste medium was removed from the flasks and rinsed with a pre-warmed (37OC) 
trypsin/EDTA (TV) solution (0.25% trypsin (Gibco, 25090-028), 0.01% EDTA 
(Sigma, EDS) solution in Phosphate Buffered Saline (Dulbecco A) (Oxoid, BR0014G). 
The purpose of this was to inhibit any naturally occurring trypsin inhibitor which 
would be present in residual serum. Fresh TV was then placed on cells (4mL/75cm2 
flask or 10ml/175cm2flask) and the flasks incubated at 37 "C until the cells were seen 
to have detached (5-l0rnin). The trypsin was deactivated by addition of an equal 
volume of growth medium (i.e. containing 5% serum. The entire solution was 
transferred to a 3011-11 sterile universal tube (Sterilin 128a) and centrifuged at 1,000rpm 
for Smin. The resulting cell pellet was resuspended in pre-warmed (37OC) fresh growth 
medium, counted (Section 2.5.3.) and used to re-seed a flask at the required cell density 
or to set up an assay. 
Table 2.2 Preparation of basal media 
2.5.2 CeM Counting 
Cell counting and viability determinations were carried out using a trypan blue (Gibco, 
1520-012) dye exclusion technique. 
An aliquout of trypan blue was added to a sample from a single cell suspension in a 
ratio of 1:5. After 3 min incubation at room temperature, a sample of this mixture was 
applied to the chamber of a haemocytometer over which a glass coverslip had been 
placed. Cells in the 16 squares of the four outer comer grids of the chamber were 
counted microscopically, an average per corner grid was calculated with the dilution 
factor being taken into account and final cell numbers were multiplied by lo4 to 
determine the number of cells per ml (volume occupied by sample in chamber is O.lcm 
x 0.Olcm i.e. 0.0001cm3 therefore cell number x 
lo4 is equivalent to cell per ml). Non-viable cells were those which stained blue while 
viable cells excluded the trypan blue and remained unstained. 
2.5.3 Cell Freezing 
To allow long term storage of cell stocks, cells were frozen and cryo-preserved in 
liquid nitrogen at temperatures below -1 80°C. Once frozen properly, such stocks 
should last indefinitely. 
Cells to be kozen were harvested in the log phase of growth (i.e. actively growing and 
approximately 50-70% confluent) and counted as described in Sections 2.5.2. Pelleted 
cells were re-suspended in serum and an equal volume of a DMSOISenun (1:9, vlv). 
This solution was slowly added dropwise to the cell suspension to give a final 
concentration of at least 5x10~ cells/ml. This step was very important as DMSO is 
toxic to cells. When added slowly the cells had a period of time to adapt to the 
presence of the DMSO, otherwise cells may have lysed. The suspension was then 
aliquoted into cryovials (Greiner, 122278) which were then quickly placed in the 
vapour phase of liquid nitrogen containers (approximately -80°C). After 2.5 to 3.5 
hours, the cryovials were lowered down into the liquid nitrogen where they were stored 
until required. 
2.5.4 Cell thawing 
Immediately prior to the removal of a cryovial from the liquid nitrogen stores for 
thawing, a sterile universal containing growth medium was prepared for the rapid 
transfer and dilution of thawed cells to reduce their exposure time to DMSO freezing 
solution which is toxic at room temperature. The suspension was centrifuged at 1,000 
rpm for 5 min, the DMSO-containing supernatant removed and the pellet re,suspended 
in fresh growth medium. A viability count was canied out (Section 2.5.2.) to determine 
the efficacy of the freezinglthawing procedures. Thawed cells were placed into tissue 
culture flasks with the appropriate volume of medium and allowed to attach overnight. 
After 24 hours, the cells were re-fed with fresh medium to remove any residual traces 
of DMSO. 
2.5.5 Sterility Checks 
Sterility checks were routinely carried out on all media, supplements and trypsin used 
for cell culture. Sample of basal media were inoculated into Tryptone Soya Broth 
(Oxoid CM0129) and Thioglycollate Broth (Oxoid CM173) and were incubated at 
25OC and 35°C respectively. Tryptone Soya Broth when incubated at 25°C will detect 
for the presence of fungus while Thioglycollate Broth when incubated at 35°C will 
detect for the presence of aerobic and anaerobic bacteria. Growth media (i.e. 
supplemented with serum and L-Glutamine) were sterility checked at least 2 days prior 
to use and were subsequently examined for turbidity and other indications of 
contamination. 
2.6 Mycoplasma Analysis 
Mycoplasma examinations were canied out routinely (at least every three months) on 
all cell lines used in this study. 
2.6.1 Indirect staining Procedure 
In this procedure, Mycoplasma-negative NRK cells (a normal rat kidney fibroblast 
line) were used as indicator cells. As such, these cells were incubate with supernatant 
from test cell lines and then examined for Mycoplasma contamination. NRK cells were 
used for this procedure because cell integrity is well maintained during fixation. A 
fluorescent Hoescht stain (Sigma H6204) was utilised which bind specifically to DNA 
and so will stain the nucleus of the cell in addition to any Mycoplasma DNA present. A 
Mycoplasma infection would thus be seen as small fluorescent bodies in the cytoplasm 
of the NRK cells and sometime outside the cells. 
NRK cells were seeded onto sterile coverslips in sterile Petri dishes at a cell density of 
2x10~ cells per ml and allowed to attach overnight at 37'C in a 5% C 9  humidified 
incubator. lml of cell-free (cleared by centrifugation at 1,000rpm for 5 min) 
supernatant from each test cell line was then incubated onto a NRK Petri dish and 
incubated as before until the cells reached 20-50% confluency (4-5 days). After this 
time, the waste medium was removed from the Petri dishes, the coverslips washed 
twice with sterile PBS, once with a cold (0-4OC spark proof i?idge for 15min) 
PBSICarnoys (50150) solution and fixed with 2ml of chilled (-20°C spark proof fkeezer 
for 15min) Carnoys solution (glacial acetic acid:methanol-l:3) for 10 min. The fixative 
was then removed and after air drymg, the coverslips were washed twice in UHP water 
and stained with 2ml of Hoechst for 10,min. 
From this point on, work proceeded in the dark to limit quenching of the fluorescent 
stain. 
The coverslips were rinsed three times in PBS. They were then mounted in 50% (vlv) 
glycerol in 0.05M citric acid and 0.1M disodium phosphate and examined using a 
fluorescent microscope with a UV filter. ' 
Proteomic techniques 
BrdU experiment 
DLKP cells (passage 32) were inoculated into 175cm2 flasks at a density of 5x10~ cells 
per flask and were incubated for two days at 37OC. BrdU (sigma, B5002) powder was 
reconsitiuted in UHP water to a stock concentration of lOmM and the resultant solution 
was filter sterilised through a sterile 0.22pm filter (Millipore SLGV), aliquotted into 
sterile vials and stored at -20°C. BrdU at a concentration of 10pm was then added to 
the cells. The medium was replaced with fresh drug containing medium 4 days later. 
After 7 days of exposure to BrdU the cells were harvested. 
Protein Preparation for 2D-electrophoresis 
The cells were removed from adherent culture by trypsinisation. Trypsin was 
neutralized by addition of media, and cells were subsequently washed twice in cold 
PBS and twice with cold sucrose-tris (IOmM sucrose, 100mM Tris, pH 8.0) buffer. 
Cells were lysed using a buffer containing (4% (w/v) CHAPS, 7M Urea, 2M Thiourea, 
lOmM Tris-HCL, 5mM Magnesium Acetate pH 8.5 plus DNase) at a concentration of 
3 x lo7 cells per ml. Cells were passed through a sterile 18 gauge syringe until the 
solution became homogenous and non-viscous and was then incubated at room 
temperature for 1 hour. Insoluble material was removed by centrifugation at 14,000rpm 
for 20mins at 4OC. Protein concentration was determined using the Bradford protein 
assay kit (BioRad) as per manufactures instructions. The protein lysates were stored at 
-80°C until used. 
2.7.3 Cy-Dye labeling 
Cell lysates prepared as described in section 3.10.2 were labeled with N-Hydroxy 
succinimidyl ester-derivatives of the cyamine dyes Cy2, Cy3 and Cy5 as follows. 
Typically, samples yielded 2-10pgIpl protein and 50pg of protein from total cell lysate 
were minimally labeled with 1p1 solution containing either 200pmol of either Cy3 or 
Cy5 per comparison on the same 2D gel. Labelling reactions were performed on ice in 
the dark for 30mins and then quenched with a 1p1 of lOmM free lysine per 200pmol of 
Cy Dye for 1Omins on ice. A pool of all samples was also prepared and labeled with 
Cy2 to be used as a standard on all gels to aid image matching and cross-gel statistical 
analysis. The Cy3 and Cy5 labelling reactions (5Opg of each) lkom each lysate were 
mixed and run on the same gels with an equal amount (50pg) of Cy2-labeled standard 
(Alban et al, 2003). In each 2D-DIGE experiment a total of 3 biological replicates were 
used for each group. Each biological replicate was run as technical duplicates. 
Protein Separation by 2-DE 
Immobilized 18cm linear pH gradient (IPG) strips, pH4-7, were reyhdrated in 
rehydration buffer (7M Urea, 2M Thiourea, 4% CHAPS, 0.5% IPG Buffer, 5OmM 
DTT) overnight, according to the manufactures guidelines. Isoelectric focusing was 
performed using an IPGphor apparatus (GE Healthcare) for a total of 48kVh at 20°C, 
50mA. Strips were equilibrated for 20mins in 50mM Tris-HCL, pH8.8, 6M Urea, 30% 
(vIv) glycerol, 1% (wlv) SDS containing 65mM DTT and then for 20mins in the same 
buffer containing 240mM Iodacetamide. Equilibrated IPG strips were transferred onto 
18cm x 20cm 12.5% uniform polyacrlamide gels poured between low fluorescence 
glass plates. Strips were overlaid with 0.5% (wlv) low melting point agarose prepared 
in 2X concentration SDS ruming buffer containing bromophenol blue. Gels were run 
using the Ettan Dalt 12 (GE Healthcare) at 2.5 Wlgel for 30mins then 1 OOW at 1 O°C 
until the dye front had run off the bottom of the gels. All images were collected on a 
Typhoon 9400 Variable Mode Imager (GE Healthcare). 
Image Acquisition and Analysis 
The Cy-dye labeled gels were visualised using a Typhoon 9410 (GE Healthcare). 
Excitation and emission wavelengths were chosen specifically for each of the dyes 
according to manufacturer's recommendations. Images were preprocessed to remove 
areas extraneous to those of interest using ImageQuant v6.5 (GE Healthcare). Intra-gel 
analysis was performed using DeCyder DIA (Difference In-gel Analysis) v6.5 (GE 
Healthcare). Inter-gel matching and statistical analysis were performed using DeCyder 
BVA (Biological Variance Analysis) v5.0 (GE Healthcare). The DeCyder DIA 
program uses a normal distribution model to determine the differentially expressed 
spots. Each protein in the individual sample is represented in the pooled standard, thus 
a comparison between the test sample and the identical protein in the standard can be 
used to generate a ratio of relative expression. 
2.7.6 Preparation of plates for spot picking 
Low fluorescent plates were polished with lint free wipes soaked in methanol and 
allowed to dry at room temperature for 10rnins. During this time the Bind Silane 
solution (8mls Ethanol, 200~1 Glacial Acetic Acid, lop1 Bind-Silane, 1.8mls UHP) 
was prepared. 1.5mls of the Bind Silane solution was applied evenly using a lint free 
wipe to one side of each glass plate. The glass plates were placed in a rack for 90mins 
taking note of which side Bind Silane had been applied and were covered with 
aluminium foil to prevent dust particulates adhering to the surface of the plates. Plates 
were again polished with a lint free wipe. The Bind Silane plates were place together 
with their accompanying space plate such that the Bind-Silane surface is in contact 
with the spacers on the spacer plate. For preparative gels proteins samples were 
prepared as described in section 3.10.2. A total of 300pg of protein was loaded on to 
each preparative gel. Loading of protein samples onto IEF strips was the same as with 
loading labeled protein samples as described in section 3.10.4. 
2.7.7 Silver staining of 2D electrophoresis gels 
Cell samples for silver staining were prepared as for DIGE analysis but are not labelled 
with Cy dyes. Samples are separated by 2D Gel Electrophoresis as for Cy Dye labelled 
proteins and processed as follows: 
(1) Fixing: gels are placed in fixing solution for a minimum of 30 minutes. 
(2) Washing: Using the outlet on the gel box, the fixing solution was carefully drained 
out. 150ml of water was added to rinse and the gel was placed on a belly dancer for 
five minutes. The gel was rinsed a total of three times. Sensitizing: After the third 
wash, the gel box was drained and approximately 200ml of sensitizing solution was 
added before returning to the belly dancer for 30 minutes. 
(3) Washing: Then using the method outlined above, three 10 minute washes were 
carried out with distilled water. Silver Reaction: Following the silver step, a further 
two washes were carried out. Each wash was a minimum of 5 minutes. 
(4) Developing: 2001111 of developer was added to the gel and allowed to develop on 
the belly dancer until protein spots appeared, something in the region of 20 minutes. 
(5) Stopping: When the desired amount of spots had appeared on the gel, the 
developing was stopped with the addition of 200ml of stopping solution and the gels 
returned to the belly dancer for l0min. 
(6) Storage: For medium to long-term storage the gels were kept in distilled water. All 
equipment used in the procedure was cleaned using warm water and detergent before 
rinsing with distilled water. 
See table 2.3 below for reagent preparations. 
Table 2.3 Preparation of silver staining required for 6 gels 
Sodium Acetate / 7001111 distilled water 
distilled water 
2.7.8 Colloidal staining of 2D-Gels, Imaging and Spot matching to BVA 
Preparative 2D-gels were prepared as described in section 3.10.4 were removed from 
the DALT 12. The spacer plates were removed fiom the platelgel sandwich using 
wedging action with the "wonder wedge" (GE Healthcare). The spacer plate was 
removed fiom cleaning later. The polyacrylamide gel fixed to the low fluorescent plate 
was allowed to fix in a solution of 7% Glacial Acetic Acid, 40% Methanol for at least 
60mins in a plastic container under agitation. Brilliant Blue G-Colloidal concentrate 
(Sigma B2025) was diluted in UHP water at a ratio of 1 :4. Immediately before staining 
the colloid~s were activated with Methanol. This solution was mixed with severe 
agitation for 30 seconds as it is important in order to activate the colloidals. The 6xing 
solution was removed from the gels and activated colloidal solution was poured on 
each gel. Gels were allowed to stain for 1-4 hours under vigorous agitation. Staining 
was complete when the gels appeared dark blue and highly abundant protein spots are 
clearly visible. Decant colloidal staining solution to a waste bottle and rinse the gel and 
container with UHP to remove as mich of the remaining stain as possible. Destaining 
solution composed of 10% Acetic Acid, 25% Methanol and 65% UHP (vlv) was 
poured onto each gel and was agitated for 30 seconds. Tlie gels were rinsed with 25% 
Methanol and allowed to destain in 25% Methanol for up to 24 hours. Destaining was 
stopped as soon & the gel background became clear. Two reference marker stickeis 
were placed on the back of each plate and then plate was scanned using Lab Scan 
Software. The image was imported into Image Master and spots were detected. The 
location of the reference markers were assigned (IRI for left reference and IR2 for 
right reference marker). A single DM file was created for the detection of spots and 
reference marker locations. Spot map was exported and imported into the BVA file 
created for the DIGE experiment for which the preparative gel was part of. Matching 
mode was selected in the BVA experiment file and landmark mode was activated. 
Obvious highly abundant spots present in distinct protein patterns were matched 
manually in this mode. The software was then htructed to match image to experiment 
using these landmarks. Pick spots were displayed in match mode gel images by 
alteration of image preferences. Matching of these protein spots between DIGE images 
prep gel images were checked individually and proteins that were matched incorrectly 
were corrected. Where the correct spot could not be found the spot was lefl unmatched. 
A pick list was then exported to the Spotter. 
Proteomics Automated Workflow 
The automated proteomic workflow used in our laboratory includes a logical sequence 
of picking, digestion, spotting, MS analysis and automatic protein database searching. 
The robots used for the first three parts of this process are ETTAN robots (GE 
Healthcare) the output files provided at each stage are directly usable with each robot 
however they are not in a format directly usable for the Ettan Pro MALDI-TOF MS or 
nanoLC ESI. 
Automated spotting of peptide sample and matrix was carried out using the ETTAN 
spotter with the dried-droplet method. The peptide sample was applied to the target 
slide and was mixed with an equal volume of matrix. 
The result of automation is the fact that experiments are conducted in exactly the same 
way each time, samples are handled in the same conditions, and the results are 
therefore more consistent. 
The Ettan Pro MALDI-TOF has a high degree of automation allowing efficient 
detection of peptide fragment ions that can automatically calibrated and inputted into 
ProFound database search engine. 
2.8.1 Spot picking of protein spot gel plugs from 2D-gels 
Preparative gels stained as described in section were placed in a plate holder on the 
Ettan spot picker robot (GE Healthcare). Plates were positioned so that the reference 
markers would appear between the two white strips on the plate holder. The plate was 
secured in position by positioning of clamps on the edges of the plates and tightened 
with screws. The solution inlet pipe was removed from the 20% Ethanol storage bottle 
and placed in LC-MS grade water bottle (Sigma). The line was primed 20 times to 
replace all 20% Ethanol in the line. The pick list generated was imported into the spot 
picker software and the robot was instructed to automatically detect the reference 
markers. Upon detection of the reference markers the instrument instructs the user to 
insert an appropriate number of microtitre plates on the plate holder stand. A directory 
file is then created allowing for the tracking of spots along the processes of picking, 
digestion and spotting. Microtitre plates containing gel plugs were sealed with foil 
wrapping and stored at 4°C. 
2.8.2 Destaining of gel plugs and protein digestion 
Plates ready for digestion were placed in appropriate positions in the Robot Digestor 
(GE Healthcare). The files corresponding to the microtitre plate placed in the robot 
were uploaded onto the Digestor software. The water surrounding the gel plugs were 
removed and the gel plugs were destained with three twenty minute washes with 50% 
Methanol containing 20mM Ammonium Bicarbonate (SIGMA). The gel plugs were 
then given two fifteen minute washes with 70% Acetonitrile (SIGMA). The gel plugs 
were allowed to air dry for a minimum of 60 minutes. A working stock of Sequence 
gradi trypsin (Promega V5280) was prepared. The trypbin was reconstiwed by the 
addition of 200pl of Acetic Acid buffer supplied by the manufacturer. Working stock 
of this trypsin solution was made by the addition of 1.4ml of a 40mM Ammonium 
Bicarbonate, 10% Acetonitrile solution in LC-MS grade water resulting in a lOpg/ml 
trypsin solution. The robot was instructed to add lop1 of this 10pgIml trypsin solution 
to each gel plug. The microtitre plate was wrapped in foil and incubated at 37OC 
overnight. 
The following day the microtitre plate was removed fYom the incubator and returned to 
the digestor robot. A new microtitre plate was placed directly below the exisiting plate 
and the robot was instructed to carry out to two twenty minute peptide extractions with 
50% Acetonitrile, 0.1% Trifluoroacetic Acid (Sigma). Upon transfer of the protein 
digests to the new microtitre plate, the plate was then placed in a SpeedVac 
Concentrator (Thermo) for 60 minutes to desiccate the peptides. Once the plate was 
fully dried the plates were stored at -20°C. 
2.9 Preparation for MALDZ-ToF Analysis 
2.9.1 Direct sample spotting 
Dried peptides were reconstituted in 3~10.1% TFA and 0.4~1 was spotted onto 
MALDI ToF target slides with an equal volume of matrix (saturated a-cyano-4- 
hydroxycinnamic acid (LaserBio Labs) in 5O%Acetonitrile/O.l%TFA) using Ettan 
Spotter (GE Healthcare). 
All samples were allowed to air-dry at room temperature. 
2.9.2 Sample desalting and concentration using CIS Zip Tip (Millipore) 
Peptides were resuspended by adding 10pL of wash solution (O.l%TFA) to each well. 
After attaching a ZipTippc18 pipette tip onto a 10pL pipettor the tips were prewet by 
aspirating the wetting solution (100% Acetonitrile) two times and this was dispensed to 
waste. The tip was wetted again with a second wetting solution (50% Acetonitrile) two 
times and this was dispensed to waste. Th ZipTips were then equilibrated by aspirating 
wash solution (O.l%TFA) through the tip a total of ten times. Peptides were bound to 
ZipTips by aspirating and dispensing (cycling) the resuspended digests through the tips 
a total of five times. The tips were then washed by aspirating wash solution (O.l%TFA) 
and dispensing the eluate to waste a total of five times. The purified peptide digests 
were eluted from the ZipTips by aspirating 1pL of elution buffer 
(50%AcetonitriletO.l%TFA containing saturated a-cyano-4-hydroxyxinnamic acid 
(LaserBio Labs)). MALDI matrix solution and this solution was then applied directly 
onto a MALDI target. A total of three elutions were carried out on all peptide samples 
bound to ZipTips with the final elution mixed with a commercially available peptide 
standard mixture (Pep4 Laser BioLabs). 
2.10 MALDI TOF MS 
Peptide-mass fingerprinting was performed using Ettan MALDI-ToF Pro. The 
instrument setting was reflector mode with 175 ns delay extraction time, 60-65% grid 
voltage and 20kV accelerating voltage. Laser shots at 250 per spectrum were used to 
acquire the spectra with mass range from 600-3000Da with 8-shot mode. A total of 
three spectra were generated for each sample analysed. MALDI-generated mass 
spectra were internally calibrated using trypsin peaks or commercially available 
peptide standards (Pep4 Laser BioLabs). The peptide masses were searched against the 
National Centre for Biotechnology Information (NCBI) Homo-sapiens database using 
proFoundTM. One missed cleavage per peptide was allowed and an initial mass 
tolerance of lOOppm was used in all searches. Fixed carbanidomethylation of 
cysteines and partial oxidation for methionine was assumed. 
MALDI-time of flight (ToF) MS was canied out using Ettan pro MALDI-ToF Mass 
Spectrophotometer (GE Healthcare). Peak lists were generated and calibrated against 
internal trypsin autolysis peaks (m/z 842.501 and 221 1.104) and or commercially 
available peptide standards (Pep 4 LaserBio Lab). PMF identifies a protein by 
measuring the molecular mass of all major trypsin products and matching these 
molecular masses using the NCBI database with ProFound. Proteins were identified 
using ProFound with a mass tolerance of Jrl- 0.2 m/z, a maximum of 1 missed 
cleavage, fixed carbarnidomethylation of cysteines and partial oxidation of 
methionines. 
Tryptically digested samples were resuspended in 20pL of a LC-MS grade water 
containing O.l%TFA and analysed by one-dimensional LC-MS using the E t t s  
MDLC system (GE Healthcare) in highthroughput configuration directly connected to 
a ~ i n n i ~ a n ~ ~  ~ ~ ~ ~ ~ ( ~ h e r m o  Electron). Sa ples were concentrated and desalted on 
RPC trap columns (zorbaxTM 300SB C18,0.3mm x 5mm, Agilent Technologies) and 
the peptides were separated on a nano-RPC column (zorbaxTM 300SB C18,0.075mm x 
1 OOmrn, Agilent Technologies) using a linear acetonitrile gradient from 0-65% 
Acetonitrile @bedel-de Ha& LC-MS grade) over 180 minutes directly into the LTQ 
via a lOpm nanoESI emitter (Presearch FS360-20-10-CE-20). Thermo linear ion trap 
mass spectrometer was used for MSNS. A scan time of -0.15 s (one microscans with 
a maximum ion injection time of 1Oms) over an mlz range of 300-2000 was used 
followed by MSMS analysis of the 3 most abundant peaks from each scan which were 
then excluded for the next 60 seconds fogowed by MSIMS of the next next three 
abundant peaks which in turn were excluded for 60 seconds and so on. A "collision 
energysetting of 35% was applied for ion fragmentation and dynamic exclusion was 
used to discriminate against previously analysed ions (data dependent analysis). 
All buffers used for nanoLC separations contained 0.1% Formic Acid (Fluka) as the 
ion pairing reagent. Full scan mass spectra were recorded in profile mode and tandem 
mass spectra in centroid mode. The peptides were identified using the information in 
the tandem mass spectra by searching against SWISS PROT database using 
SEQUEST~~ using an Xcorr value of 1.5 for singly charged peptides, 2.0 for doubly 
charged peptide and 2.5 for triply charged peptides. 
3.0 Results 
Previous studies in this laboratory have shown that 10pM 5,2'-Bromodeoxyuridine 
(BrdU) induces cytokeratin 8, 18 and 19 protein expression in the DLKP cell line 
(McBride et al, 1999). Induced a2-,PI-integrin has also been observed (Meleady and 
Clynes 2001) and elevated levels of eIF4E (Walsh et al, 2003) . 
In this study we ultilised 2-dimensional DIGE gel electrophoresis followed by Mass 
Spectrometry (MS) analysis to identify and quantify specific protein expression 
changes in human lung carcinoma cell line DLKP following exposure to the 
differentiation-modulating agent 5-bromodeoxyuridine. 
3.1 5 day treatment of DLKP with lOpM BrdU 
DLKP cells (passage 32) were seeded in 175cm2 flasks at a concentration of 5x10' 
cells per flask. Three biological replicates consisting of 2 control (untreated) and 8 
(treated) flasks per replicate were set up in three separate 37°C incubators, on three 
consecutive days labeled A, B and C. Two days after each replicate set up, 10pM 
BrdU was added to each of the 8 treated labeled flasks but not to the 2 control 
labeled flasks. The medium in each flask was replaced with freshl0pM BrdU four 
days later in the case of the treated flask while the control had its media renewed. 
Alter 7 days the cells were harvested (materials and methods 2.7.1.). 
Following harvesting, the cells were prepared for 2DE analysis (materials and 
methods 2.7.2) and stored at -80°C until use. 
3.2 Protein Separation by 2-DE 
2-DE protein separation was carried out on the control and BrdU treated samples. 
Sample were separated in the IS' dimension (IEF) over the pH range of 4-7 and then 
in the 2"* dimension (materials and methods 2.7.4) 
3.3 Quality control of protein lysates 
Prior to analysis by DIGE, all protein extracts were analysed by 2D electrophoresis 
followed by silver staining (materials and methods section 2.7.7) to ensure extracts 
used were good quality and had not been adversely affected by protein extraction 
(figure 3.1) 
Figure 3.1 AU protein lysates for DIGE analysis were separated by IER over the plrange 4-7 
and run on 2D electrophoresis gels and visualised by silver staining to ensure the quality of 
protein samples. An example of a good quality sample showing clear well defmed protein spots 
with no sign of breakdown is shown above 
3.4 DIGE Analysis of Control versus BrdU Treated DLKP 
The experimental design for DIGE analysis of DLKP control versus BrdU treated is 
outlined in table 1. Three biological replicates of each control and test samples were 
used for the DIGE analysis and labeled with Cy-Dyes (see materials and methods 
2.7.3.). Each gel contained 50pg of control, 50pg test sample and 50pg of internal 
control. Each gel was run in duplicate, resulting in a total of 6 gels in the experiment 
(table 3.1). 
Stock Cy dye at lnMIp1 
Working stock at 200prn/pl 
Table 3.1 Experimental Design for 2D-DIGE comparison of control versus BrdU-treated 
DLKP. 
3.5 Image Analysis 
DIGE gels were scanned with a Typhoon 9400 scanner (GE Healthcare) producing a 
Cy2, Cy3 and Cy5 image for each gel at excitation wavelengths of 488,532 and 
633nm and emission wavelengths of 520,580 and 670 nm respectively. Three 
images corresponding to three samples labeled with three different CyDyes are 
generated in one gel (figure 3.2). Image analysis was carried out with DeCyder 6.5 
software (GE Healthcare) using the Batch Processor facility. The Batch Processor 
automatically analysed the scanned images first using the Differential In-gel 
Analysis (DIA) module where the Cy2, Cy3 and Cy5 image from each gel was 
nonnalised and the Cy3 and Cy5 samples compared with the Cy2 internal standard. 
Histograms are generated by DeCyder DL4 software, plotting spot frequency (left y- 
axis) against the log volume ratio (x-axis) and a normal distribution model was fitted 
to the main peak of the frequency distribution. A 1.5 standard deviation model was 
set as threshold. The threshold values are represented by vertical black lines in the 
histogram, and the differentially expressed spot features are shown as blue spots and 
red spots (figure 3.3). The DL4 is only allowed for single pairwise comparisons and 
cannot be used to analyse the data generated by all gels for group statistical analysis. 
The number of increased expressed spot, decreased expressed spot, similar 
expressed spot, and threshold value of control and treated are shown in table 3.2. To 
identify differentially expressed prote& spots across these 6 gels, the results from 
the intra-gel comparison (6 DL4 files) were imported in the BVA module of 
DeCyder software. One of the Cy2 images containing the most detected protein 
spots was selected as the Master, and the other 5 internal standard images were 
matched sequentially to it (materials and methods 2.7.5.). 
Figure 3.2. Representative example of 2-D DIGE 
DIGE images of DLKP control and BrdU treated 
of Cy2-labeled pooled standard (equal amount of 
labeled control samples; @) 50pg of Cy5-labeled 
: analytical gels: (A) colour overlay of 2-D 
I samples labeled with Cy3 and Cy5. (B) 50pg 
'control and treated sample); (C) 50pg of Cy3- 
BrdU treated sample. 
' . . . . . I " . .  II&-., 
Gel 4 
Gel 5 
Figure 3.3. Determining the differentially expressed proteins in the 6 gels. The histograms were 
generated by DeCyder DIA software, plotting spot frequency (left y-axis) against log volume 
ratio (x-axis) and a normal distribution model (red line) was fitted to the main peak of the 
frequency distribution histogram. A 1.5 fold upldown regulation was set as threshold. The 
threshold values represented by vertical black lines in the histogram and the differentially 
expressed spot features are shown as blue spots and red spots. 
Gel 1 
Threshold value 1.5 
Decreased: 127 (5.9%) 
Increased: 98 (4.6%) 
Similar: 1919 (89.5) 
Table 3.2. Result of Difference In-Gel Analysis of Control vs Treated BrdU DLKP 
Gel 4 
Threshold value 1.5 
Decreased: 147 (7.1%) 
Increased: 99 (4.8%) 
Similar 1831 (88.2%) 
Gel 2 
Threshold value 1.5 
Decreased: 97 (4.8%) 
Increased: 145 (7.1%) 
Similar: 1787 (88.1%) 
Gel 3 
Threshold value 1.5 
Decreased: 120 (5.6%) 
Increased: 62 (2.9%) 
Similar 1976 (91.5%) 
Gel 5 
Threshold value 1.5 
Decreased: 75 (3.5%) 
Increased: 140 (6.6%) 
Similar: 1914 (89.9% 
Gel 6 
Threshold value 1.5 
Decreased: 129 (6.1%) 
Increased: 62 (2.9%) 
Similar: 1929 (91%) 
To identify differentially expressed spots across all the 6 gels, the results from the 
intra-gel comparision (6 DIA fies) were imported into the Biological Variation 
Analysis (BVA) module of DeCyder software. 
This paired ratio data was then utilised in the Biological Variation Analysis (BVA) 
module when the Cy2 internal standard images from the gels were matched, 
allowing the spot ratios between the gels to be compared. A list was thus generated 
containing the protein spot ratio and T-test value for each spot (table 3.3). 
The protein spots were assigned a Master Number. The location of the Master 
Number to its assigned protein spot can be seen in their treated and control gel in 
figure 3.4 and 3.5. 
Relevant spots were selected by narrowing the filter settings to b h1.5 with a T-test 
confidence of 2 95% (P 5 0.05) and visually confirmed not to be artifacts. 
43 protein spots displayed statistical significant differences in their level of 
expression between DLKP control and BrdU Treatment (table 3.3). 25 protein spots 
were up-regulated and 18 were down-regulated. 
Two examples are shown using the DeCyder BVA results to visualise up and down 
differentially regulated protein spots (figure 3.6+3.7). The expanded DIGE spot 
profile of spot 2213 which is 3-fold up regulated with corresponding 3D view and 
graphical view of the normalized log abundance of the protein spot relative to the 
standard for each biological replicate gel. The DIGE spot profile of spot 151 1 which 
is 1.5-fold down regulated with corresponding 3D view and graphical view of the 
normalized log abundance of the protein spot relative to the standard for each 
biological replicate gel. 

Ngure 3.4.2D-DIGE scan of DLW Control sample. 43 Protein spots were identified by their 
master number as confirmed differentially-regulated spots. 

Figure 3.6. Expanded DIGE spot profde of spot 2113 (A), the corresponding 3D view (B) and a 
graphical view of the normalized log abundance of the protein spot relative to the standard for 
each biological replicate gel (C). 
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Figure 3.7. Expanded DIGE spot profde of spot 1511 (A), the corresponding 3D view (B) and a 
graphical view of the normalized log abundance of the protein spot relative to the standard for 
each biological replicate gel (C). 
3.6 Preparative 2D gels for protein Identification 
To identify the differentially expressed proteins preparative DLKP control and BrdU 
treated 2D gels were run (material and methods 2.7.8). Briefy, preparative 2D gels 
were prepared by loading 350pg total protein per gel. The gels were stained with 
Collodial Coomassie Blue (Sigma) and scanned using Labscan software. Scanned 
images were imported into Imagemaster version 5 (GE Healthcare). Differentially 
regulated proteins from Table 3.3 were then matched to the DLKP control and 
treated preparative gels (figures 3.8 + 3.9) and a protein pick list was prepared using 
the spot picker software (GE Healthcare). 
Using the Ettan Spot Picker (GE Healthcare) the 43 differentially regulated proteins 
were picked and placed into a 96 well plate (materials and methods 2.8.1). 
Destaining and digestion of the protein plugs was canied out using the Ettan 
Digestor (GE Healthcare) and overnight digestion using sequence grade trypsin 
(Promega) at 37OC was canied out (materials and methods 2.8.2). 
The digested proteins were either spotted onto MALDI-Target slides for 
identification by MALDI-ToF MS or using MSJMS in conjunction with 
nanoelectrospray (MDLC-LTQ) (materials and methods 2.9 and 2.1 1 respectively). 
Figure 3.10 below for a flow chart to illustrate the flowpath involved in gel 
electrophoresis to protein identification. 
Figure 3.8. Representative 2D image of the preparative DLKP Control gel. 350pg of protein 
sample from DLKP was tirst separated by IEF using Immobiline Drystrip pH 4-7, followed by 
second dimension separation with a 12.5% SDS-PAGE. The gel was post stained with coUoidal 
coomassie blue. Arrows indicated differentially expressed proteins labelled with their master 
number, and were excised from the gel and subjected to in-gel digestion. 
Figure 3.9. Representative 2D image of the preparative DLKP BrdU Treated gel. 350pg of 
protein sample from DLKP was f m t  separated by IEF using Immobiline Drystrip pH 4-7, 
followed by second dimension separation with a 12.5% SDS-PAGE. The gel was post stained 
with colloidal Coomassie blue. Arrows indicated differentially expressed proteins labelled with 
their master number, and were excised from the gel and subjected to in-gel digestion. 
Gel electrophoresis 
I I 
I I In-gel %tic digestion 
R I 
I MALDI-MS 1 
peptide digest masses 
for best match 
Database search of 
fragmentation pattern 
Figure 3.10. A flow chart to illustrate the steps involved in protein identifiation from 2-D gels 
by MALDI and tandem mass spectrometry. 
3.7 Matrix-Assisted Laser Desorption Ionization (MALDI) Time of Flight 
(Tow 
In Matrix-Assisted Laser Desorption Ionization (MALDI), the digested peptide 
sample is embedded in a low molecular weight, UV-absorbing matrix that enhances 
sample ionization called a-cyano-4-hydroxycinnamic acid (CHCA). The role of the 
matrix is to facilitate intact desorption and ionization of the sample. The matrix is 
present in vast excess of sample, and therefore isolates individual sample molecule. 
The protein can be identified from its peptide mass map or fingerprint, if the 
peptides from a sufficiently unique pattern when checked against the NCBI- 
PROFOUND database. At least an expected value of 0.01 (99% confident) or less 
was considered as a successful identification. 
Mass spectrometry can be carried out automatically with the Ettan Pro MALDI-TOF 
with the laser intensity and slide position automatically adjusting to give the best 
ionization of the peptides present in each sample (materials and methods figure 
2.10). 
The use of an external calibrant in the first position on the MALDI target to calibrate 
the target slide is routinely used in our laboratory (figure 3.1 1 A) however during 
this study it was observed that peptide mass accuracy obtained using this method 
was poor leading to ambiguous protein identifications following database searches. 
The peptides masses from Spot 1678 were externally calibrated using the pep4 mix 
standard spotted on the first position on the side. Spot 1678 had been spotted on 
position twelve (24 positions in total on each slide) on the slide. The peptide list 
generated was searched using Profound. An ambiguous protein identification was 
obtained (figure 3.11 B). The same Mass spectra was then internally calibrated using 
the trypsin autodigestion peaks, Trypsin I (842.509m/z) and Trypsin I11 (2211.104 
mlz) which were present. Following a ProFound search, the protein designated "The 
Molecular Basis For The Local Conformational Rearrangement Of Human 
Phosphoserine Phosphatase" was identified with very high confidence as being spot 
1768 (figure 3.1 1 C). The mass differences between the externally calibrated and 
internally calibrated peptides from spot 1678 can be seen in figure 3.1 1 D below. 
sm r i a  
~. ~~ 
Spectrum processing method 
fragment 1-5, Angiotensin II, Neurotensin and ACTH fragment 18-39 which is used to calibrate 
a MALDI-Target Slide 



Peptides from spot number 1973 were analysed by MALDI-ToF MS. Mass spectrum 
acquisition and mass peak assignment was automatically carried out by the Ettan 
Software (figure 3.12 A). 
Peak detection was performed after automatic calibration of the mass spectrum with 
internal standards (figure 3.12 B). The Ettan Pro Evaluation software (GE 
Healthcare) can automatically search for the autoproteolytic peptide masses of 
trypsin 1, 2 andor 3 (842.509, 1046 and 22 1 1.104 respectively) and if found can 
automatically internally calibrate each spectra. The calibrated peptide masses were 
automatically searched with the NCBI database. Spot 1973 was automatically 
identified as Cofilin 1 (Homo sapiens) (figure 3.12 C). 
. 
eaks were internally calibrated after tbe software automaticaUy 
protein Cofilin 1 (C). 
Incorrect assignment of peak masses, missed assignments of peaks and incorrect 
assignment of trypsin digestion peaks resulting in inaccurate spectral calibrations are 
the main disadvantages of this automated MALDI-TOF MS analysis and database 
searching software. Manual interpretation of MALDI-ToF MS spectra by the 
addition of peptides that the software fails to identify can result in an increase in the 
number of peptides assigned to a protein and therefore improve the overall amino 
acid percentage coverage of protein identification (figure 3.13 A). The masses were 
automatically associated to peptides from spot 1973 however on manual inspection 
of the spectra, a peptide mass at 1337.594mlz had not been assigned automatically. 
When this peak was manually assigned and the peptide masses searched again there 
was approximately 8% increase in the percentage coverage (figure 3.13 A) when 
compared to the previous score (figure 3.12 C). 
Proteins that were not identified by MALDI-ToF MS with direct spotting were 
subjected to desalting and concentration using the z ip~ipTM ( illipore). 

3.8 Sample Preparation Prior to MALDI-ToF MS using ZipTipcls Tips 
zip~ipTM is a lop1 (P10) pipette tip with a bed of chromatography media fixed at its 
end such that there is no dead volume. It is intended for purifying and concentrating 
femtomoles to picomoles of peptide samples prior to analysis providing better data 
quality. The sample is aspirated and dispensed through ZipTip to bind, wash and 
elute. Recovered samples are contaminant-free and eluted in a 0 .4~1 for direct 
transfer to a MALDI-ToF MS target. 
It was not possible to ZipTip all samples as this is an expensive and time consuming 
procedure so all samples were processed using direct sample spotting with the Ettan 
Spotter. MALDI-ToF MS was canied out. GE Healthcare state that the low-salt 
digestion method used by Ettan Spot robots do not require a clean-up step. However 
all samples that were not identified with high confidence using the robot dried 
droplet method were then subjected to sample clean up and concentration with Zip 
Tips. 
Figure 3.14 shows spectra before and after desalting with ZipTipcl*. Sample before 
zip tipping produced a spectra with just one peptide and as a result poor confidence 
score from ProFound database search. Spectra t?om the same sample after ZipTip 
resulted in a concentration and desalting and now 7 peptides were present allowing 
for a high confidence result from PmFound database search. 
Although the benefits of sample clean up and concentration with Cl* ZipTips is well 
documented and observed in our laboratory, it has been noted that some high 
molecular weight peptides sometime remained tightly bound to the column after 
elution (figure 3.19). This can be problematic as the presence of trypsin I11 at 
221 1.104m/z which frequently remained bound to the ZipTip is a very useM as an 
internal calibrant. 
It has also been observed that there is some batch to batch variation in the quality of 
the ZipTips (results not shown) resulting in poor MS spectra acquired post sample 
clean up and concentration. 
ber 1425. Spectra taken before and after 
, .  .... 
3.9 Internal calibration methods for mass accuracy identifications of 
proteins by MALDI-TOF MS 
The fmt step in obtaining a peptide mass is the in-gel digestion of a protein spot by 
trypsin, a protease that specifically cuts the carboxyl-terminal of Arg or Lys residue. 
The trypsin enzyme can result in autodigestion peaks at 842.509, 1045.5642 and 
221 1.104mfz which are exploited as internal standards for mass calibration and are 
useful when internal calibrants are not added. 
Getting accurate mass values depends on how well the data is calibrated. We 
compared the MS spectrum from two different calibration protocols. (1) Internal 
calibration using trypsin autodigestion peaks, and (2) Internal calibration with 
commercially available peptide 4 standard (LaserBio Labs). 
The peptides from spot number 73 1 were desalted and concentrated using ZipTips. 
Two elutions from the Zip Tip was carried out. The first elution was directly spotted 
onto the MALDI target slide and the second elution from the same tip was mixed 
with a commercially available peptide standard. Both samples were analysed by 
MALDI-TOF MS. 
Figure 3.15 shows the spectrum ffom the first elution containing 17 peptides. Only 
one autodigestion trypsin peak is present at 842.509mlz and this is used to internally 
calibrate the 17 peptides present. M e r  peptide mass searching using ProFound, a 
low confidence protein identification is made as HSD24. 
Figure 3.16 shows the spectrum from the second elution of the Zip Tip sample 73 1 
which is mixed with commercially available peptide standards. 10 peptides are 
present from the sample and three calibrant peptides are also present (Angiotensin I1 
at 1046.5424dz, Neurotensin at 1672.918dz and ACTH fragment 18-39 at 
2465.199dz). Using the three calibrant peptides to calibrate the 10 sample peptides 
a very high confidence score for the identification of spot 73 1 is given as Aldehyde 
dehydrogenase 1 following ProFound database search. 
Poor mass accuracy of the peptides present in the first elution from the Zip Tip 
sample 73 1 as only one internal calibrant was present resulted in a low confidence 
protein identification of that sample. Using the high mass accuracy peptide measured 
from the second elution at 1700.723dz we re-calibrated the peptides measured 
from the first elution spectra using 842.509dz (trypsin autodigestion peak) and the 
sample peptides 1700.723dz. The new peptide masses were searched using 
ProFound a very high confidence score resulted matching the identification from the 
second elution as Aldehyde dehydrogenase 1 (figure 3.17). 



3.10 Identification of low molecular weight proteins by MALDI ToF MS. 
Identification of low molecular weight proteins have proved very difficult by 
MALDI-ToF MS. A combination of limited peptides available due to the size of the 
protein and some peptides ionising better that other peptides making accurate mass 
determination of these peptides difficult. 
We have discovered that a combination of manually picking the low molecular 
protein spots to give a large amount of protein available for digestion, increasing the 
laser intensity to allow some of the less dominant peptides to ionize and internal 
calibrants with pep4 has proved successful in the identification of some low 
molecular weight proteins (figure 3.18). Using the Ettan spot picker, master number 
2213 was picked, the protein plug was destained, digested and desalted and 
concentrated before being analysed by MALDI-TOF MS. The resulting peptide list 
was searched using ProFound. However a low confidence protein identification 
score was generated (figure 3.18). Using a Pasteur pipette a larger gel plug of the 
same protein spot was picked. The protein plug was destained, digested and desalted 
and concentrated prior to analysis by MALDI-TOF MS. A significant number of 
peptides were generated, the list was searched using ProFound and the resulting 
protein identification had a very high score (figure 3.18). 
Lank Expectat 
- -- 
1 0.307 gi198445451emblCAC03973.1 - T-cell 19.7 6.7 8.70 
r e ~ ~ p t w  beta chain [Homo saplens] 
- 
tank Expectation Protein information 
- 
1 0.1 gi1305827291gblAAP35591.1 -.cytochrorne c . 65.1 6.6 10.40 
oxidase subunit VIb [Homo sapiens] 
Figwe 3.18. Comparison of MALDI-TOP hiS spectra generated from peptldes from Ettan Spot 
picker sample (A) and manual picked spot'(B) (with a sterile pastew pipette). Both samples 
were cleaned up with Up'Nps. The first sample used autodigeslion peplo for intend calibrrnt 
and the second used spked calibration peptides as internal standards. , . ":-,:. . . :; L. 
. . .  . ..' 
, ,  . 
. -. : 
. . :.. ~, 
, .  . 
-11 Peptide retention on Zip 
gh the benefits of sample clean up and on have been discussed, 
g the course of this study it has been observed that some high molecular 
tides appear to bind permanently to the Zip Tip Columns. This was illustrated by 
ot no 1826 (identified as DJ-1) which was analysed by direct spotting and then by 
Zip Tip. In direct spot (dried droplet spotting method) the autodigestion peptide 
olecular weight peptides have remained bound to the Zip Tip are not present in 
, 2211.1,2229.2 and 2300.1 mlz Zip Tip sample clean up of the same sample resulted in , , 
the same high molecular peptides retained on the Zip Tip and not present in the spectra. 
, , 
3.12 Protein identification results 
Using a combination of the various techniques including direct peptide spotting, 
sample concentration and desalting, internal calibration and spot picking, 23 proteins 
were identified by MALDI-TOF MS. 10 proteins were differentially up-regulated 
and 13 were down regulated. One protein (spot 2100) was identified as two separate 
proteins (table 4). 
These proteins identified by MALDI-TOF Mass Spectrometry are list in table 3.4. 
Table 3.4 MAEDI-ToF MS Protein Identification results 
0-HUMAN - Keratln, type I 
Master 
spot  no. 
1423 
- 1425 
1432 
151 1 
1518 
1678 
1826 
1973 
2100 
2100 
Comments 
Matched 7 
peptides 
Matched 5 
peptides 
Matched 8 
peptides 
Matched 7 
peptides 
Matched 5 
peptides 
Matched 5 
pept~des 
Matched 5 
peptides 
Matched 7 
peptides 
Matched 5 
peptides 
Matched 5 
peptides 
Fold 
change 
-1.66 
-1.73 
-1.56 
-1.56 
-1.65 
1.58 
1.63 
-2.34 
2.46 
2.46 
ID 
gi1572098891emblCA14128 
4.1 - ret~noblastoma blndlng 
protein 7 lHomo saplens] 
g1162088696ldbllBAD92795 
.1 - splicing factor, 
arglninelsenne-nch 1 
(spllclng factor 2, alternate 
spllclng factor) varlant 
[Homo saplens] 
g1175465461pdbl EF7IB - 
Chain 6, Crystal Structure 
Of Human Cathepsin X 
g115748523(emblCA853072 
.1 - MAPRE1 [Homo 
saplens] 
g1I214296081gblAAM50090. 
1 - superox~de dlsmutase 
copper chaperone [Homo 
sapiensl 
g1118903311emblCAA71318 
.I Molecular Basis For The 
Local Conformational 
Rearrangement Of Human 
Phosphosenne 
Phosphatase] 
gi1333580561pdbl lPEOlB - 
Cham B, Crystal Structure 
Of The K130r Mutant Of 
Human DJ-1 
g1130582531lgblAAP35492. 
1 - cofilln 1 (non-muscle) 
[Homo sapiens] 
g1(179318(gblAAA51811.1 - 
beta-2-m~croglobul~n [Homo 
saplens] 
g112299951pdbl HLAIM - 
Cham M, Human Class I 
Histocompatlb~ilty Antlgen 
A2 (HLA-A2, Human 
Leucocyte Antigen) 
T tes t  
0.0056 
6.10E-06 
0.00031 
0.0023 
0.002 
0.00019 
2.00E-06 
0.00014 
4.40E-06 
4.4E-06 
Expected 
0.024 
0.001 
0.001 
0.000 
0.000 
0.003 
0.008 
0.000 
0.003 
0.003 
Coverage 
% 
13.6 
26.4 
37.2 
27.2 
16.4 
34.7 
22.3 
36.1 
26.9 
39.2 
p l  
4.9 
5.5 
5.5 
5.0 
5.3 
5.5 
6.5 
8.5 
6.1 
6.5 
Mw 
(kDa) 
47.60 
27.76 
27.76 
30.15 
29.52 
25.17 
21.14 
18.71 
13.83 
11.58 
Table 3.4. Identified proteins by Mass Spectrometry. Two protein Identifications from the one 
gel plug spot 2100. 
comments 
Matched 2 
peptides 
Matched 5 
peptides 
Coverage 
% 
18.39 
65.1 
Expected 
N/A for 
LTQ 
0.000 
ID 
g1I305827291gblAAP35591. 
1 - cytochrorne c oxtdase 
subunit VIb [Homo saplens1 
g1130582729lgblAAP35591. 
1 - cytochrome c ox~dase 
subun~t VIb [Homo sap~ensl 
pl 
6.5 
6.6 
T test 
7.10E-07 
2.00E-09 
Master 
spot no. 
2104 
2113 
Mw 
(kDa) 
10.30 
10.4 
Fold 
change 
2.20 
3.09 
. . . .  ~. . ~ 
~. . 
. . ~ .  
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MALDI-TOF MS Spectra results 
Master number: 234 
Identified by MALDI-TOF MS (Zip Tip)- Alpha Glucosidase IT 
Rank ectation Protein inforrna Coverag 
- - 
1 0.003 gil38371758lreflNP-055425.3 - alpha 9.9 5.9 86.27 
glucosidase I1 alpha subunit isoform 1 [Homo 
sapiens] 
Flgure 3.22 Spot 234 Vincuh 
Master number: 511 
Identified by MALDI-TOF MS (Zip Tip) - Heat shock 70Kd 
1 0.000 gi1210403861gb(MH30634.1 - heat shock 17.8 6.0 74.12 
70kD protein 98 (mortalin-2) [Homo sapiens] 
Figure a 3  Spot 511 Heat shodt7OkD 
Master number: 550 
Identified by MALDI-TOF MS (Direet spotting) - Serum Albumin 
1 0.000 gi11626481gblAAA51411.1 - albumin [80s 19.1 5.8 71.27 
taurus] 
Fipure3.24 Spot 550 Albumln 
Master number: 551 
Identified by MALDI-TOF MS (Direct spotting) - Serum Albumin 
ion Protein information 
- 
~ . 3 0 0  ~i)23307791IgblAAN17824.~ - 71.30 
albumin [Em taurus] 
Figure335 Spot 551 Albumln 
Master number: 552 
Identified by MALDI-TOE" MS (Zip Tip) - Serum Albumin 
Expectation Protein information 
. , 
.~ . 
. . 
?.' 
. ~~ 
. . 
. 
.~~ . 
..* ~, 
Master number: 674 
Direct spot analysis by MALDI-TOF MS-No Identification required Zip Tip 
ank Expectation Protein in1 
- 
1 0.409 gi121450951gblAAB58419.1 - cis Golgi- 6.5 4.7 81.92 
localized calcium-binding protein 
F i i  327 Spot 674 Calcium binding pro* 
Master number: 674 
Zip Tip resulting in identification by MALDI-TOF MS-UDP-N- 
acteylglucosamine pyrophosphorylasel 
- 
ank Expi----ion Protein information Covera 
~ ~~~~ - .  ~.~~~ ~~~~ ~ 
1 0.007 gi1556655601emblCAH72978.1- UDP-N- 10.7 6.0 57.41 
acteylglucosamine pymphosphorylase 1 
[Homo sapiens] 
RigurpJ.28 Spot 674 UDP-N-scteylglucossmioe pyrophosphorylase 1 
Master number: 731 
Identified by MALDI-TOE" MS (Zip Tip) - Aldehyde dehydrogenase 1 
1 Rank -ion Protein information Coverage p1 
1 0.001 gi121832991gblAAC51652.1 - aldehyde 19.2 6.3 55.44 
dehydrogenase 1 [Homo saplens] 
Figure329 Spot 731 Aldehyde dehydrogenase 
Master number: 780 
Identified by MALDI-TOE" MS (Direct spotting) - Splicing factor 3 
on rroreln lnrormarlon Coverage p1 Mass CkDaI 
1 0.008 gi1556659711emblCAH69930.1 - splicing 15.8 5.3 59.17 
factor 3a, subunit 3, 60kDa [Homo sapiensl 
Figure 330 Spot 780 SlicIngfaetor 31 
Master number: 810 
Identified by MALDI-TOF MS (Direct spotting) -Keratin type 1 
ank on Protein information CP 
I 
1 O.Gur g 1 ~ 5 4 7 7 4 9 ~ ~ p l P 1 3 6 4 5 ~ K l C 1 0 ~ 0 u ~ ~ ~ ~ ~ v  - 
Keratln, type I qtoskeletal 10 (Wokeratin 
10) (K10) (CK 10) 
Figure 331 Spot 810 Keratin 1 
Master number: 893 
Identified by MALDI-TOF MS (Zip Tip)- Polymerase 
ank Expectation Protein inforrnauvn Mass tkDal 
1 0.000 gi1214309831gblAAM51148.1 - polymerase 29.2 5.3 51.90 
(DNA directed), delta 2, regulatory subunR 
(50kD) [Homo sapiens] 
Figure 332 Spot 893 Polymera#e 1 
Master number: 1059 
Identified by MALDI-TOE' MS (Direct spotting) - Beta Tubulin 
1 0.000 giI180887191gblAAH20946.1 - Tubulin, beta 35.4 4.7 50.11 
polypeptide [Homo sapiens] 
Figure 333 Spot 1059 BetaTubulin 
Master number: 1412 
Identified by MALDI-TOF MS (Direct spotting) - Splicing factor 
Rank Expectation Protein information 
0.000 gi1620886961dbjIBAD92795.1 - splicing 32.6 9.3 25.78 
factor, argininelserine-rlch 1 (spl~cing factor 
2, alternate splicing factor) variant [Homo 
sapiensl 
F y w  334 Spot 1412 Splicing factor 2 
Master number: 1423 
Identified by MALDI-TOF MS- Diiect spotting - Retinoblastoma binding 
protein 7 poor confidence 
expecrarlon proreln lnrormar~on coverag 
0.024 gi1572098891emblCAI41284.1 - .6 4.9 47.t 
retinoblastoma binding pmteln 7 [Homo 
sapiensl 
~ .~ . . 
. . -  
. . . . . . . .  Master number: 1423 . .'.;.' . . : .  . . .  ..'. . . . . .  .-.I : . . . . . . . . . . .  ' . . .  
Identified by MALDI-TOF MS- Zip Tip - Retinoblastoma binding protein 
. ' .  
. .  
ank Expectation Protein information Coverage p l  
, 
I* ~~ ,.,, gi)57209888(embJCAI+.aua.~ - 16.8 5.- 
retlnoblastoma bindlng protein 7 [Homo 
sapiens] 
Figure 335b Spot 1423 Retinoblrstamn bin* protein 7 
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Master number: 1425 
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Identified by MALDI-TOF MS (Direct spottin& Cathepsin X 
.. . 
~ . .  
.~ - 
. . 
. . 1 0.002 gi175465461pdbllEF7lB - Chain 6, Crystal 33.1 5.5 27.76 
., . . .  Structure Of Human Cathepsln X , ::>,, ,, 
. ,, ;: . . 
pisure 336 Spot 1425 c.thrpoinX . , . ~, . 
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Master number: 1511 . ~. . . . ... . .  . . 
Identified by MALDI-TOF MS confidence protein 
identification :~ 
. . , , ~  . 
-. , .. 
. - 
. .L , 
. ')I 
. . .L 
. r l  
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.I. 
'II , . 
'C 
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m 
1 E 
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I 
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* 
.s 
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m 
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.m %m 
~ ~ 
Expectation 
1 0.L. gil269842831gblAAN85282.1- J-type a -. .72 
chaperone HSC2O; HSCB [Homo sapiens 
. ~ 
Fyue337a Spot 1511 Low coifidence ESC20 
. . 
Master number: 1511 
Identified by MALDI-TOF MS (Zip Tip)- MAPRE 1 
Expectation Protein information Coverage p: 
1 0.000 gi15748523lemb(CA85U172.1 - MAPREI 27.2 5.0 30.15 
[Homo sapiens] 
Prgnre337b Spot 1511 MAPRE 1 
Master number: 1518 
Identifed by MALDI-TOF MS (Zip Tip) - Superoxide dismutase copper 
chaperone 
Rank mpectatlon Coverage p1 Mass 
1 005 gi12142%081gbJAAM50090.1- superoxide 16.4 5.3 29.52 
dismutase copper chaperone [Homo sapiens] 
Figure 338 Spot 1518 Superoxide dismutaae copper chaperone 
Master number: 1678 
Identified by MALDI-TOF MS (Zip Tip) - Molecular Basis For The Local 
Conformational Rearrangement Of Human Phosphoserine Phosphatase 
Rank Expectation Protein Information 
1 0.003 gi129726394~pdbI1160IB - Chain B, 
Molecular Basis For The Local Conformational 
Rearrangement Of Human Phosphoserine 
Phosphatase 
Figure 339 Spot 1678 Molsuhr Buis For The Local Conformatiad Rmmgement  Of Iiumnn Phalphoserhe 
PLapL.tne 
Master number: 1826 
Identlfied MALDI-TOF MS (Diuect spot) - Crystal Structure Of Human Dj-1 
with a low confidence score 
Coveraoe a 
1 0.033 gi1425430061pdbllJ42IA - Chain A, Crystal J5.5 0.3 20.06 
Structure Of Human Dj-1 
Figure3AOs Spot 1826 Dj-l 
Master number: 1826 
Identified by MALDI-TOR MS (Zip Tip) - Crystal Structure Of Human Dj-1 
0.000 gi142543006(pdb)U421A - Chain A, Crystal 49.2 6.3 20.06 
Structure Of Human Dj-1 
Figurr3AOb Spot 1826 Dj-l 
. . , . ~  . 
. ~. 
. . 
. . ~ -  . ~. . Master number: 1973 
* ,  :... . 
., . ,,. 
....... 
Identified by MALDI-TOF MS (Zip Tip) - Cofilin 
.: 
~. 
~ ~ 
. . 
. ~. Is 
. . . . . . .  tank Expectal ein information Coverage PI . ~ 
Master number: 2100 
M e p o t  sample no Identification by MALDI-TOF MS 
Expectation Protein information Coverage p1 Mass [ k ~ i  
Master number: 2100 
~dentified by MALDI-TOF MS (Zip Tip) -Human Class I Histocompatibility 
- Antigen A2 and gill793181gblAAA51811.1- beta-2-microglobulin mom0 
sapiens] 
1 0.000 gi12299951pdbllHlAlM - Chain M, Human 39.2 6.5 11.58 
Uass I HlstocompaiMiih/ Antigen A2 (HlA- 
AZ, Human Leucocyte Antigen) 
---- - - -  
L - gi11793181gblAAA51811.1 - beta-2- 26.9 6.1 13.83 
rn~croglobul~n [Homo sapiens] 
-- - 
ngure3.42b Spot ZlW Two pmWmIdatbied Hanun Qu I ~ ~ A . U g a  A2 md w 
mkmgbbulin 
Master number: 2113 
Identified by MALDI-TOF MS (Zip Tip) - Cytochrome c oxidase subunit VIb 
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3.13 Protein Identification using nanoLC-MSIMS 
NanoLC-MSJMS was carried out using the Ettan MDLC (GE Healthcare) and LTQ- 
Ion Trap (Thermo). At least two peptides of experimental MSIMS data matched to 
the theoretical candidate protein internal sequence was considered as a successful 
identification. 
High-throughput configuration 
Nanobore Reverse Phase Chromatography (RPC) is a method commonly used for 
peptide separation of less complex mixtures prior to identification by mass 
spectrometry. In the typical set up, this method requires a set of two columns-an 
RPC trap and an RPC column-connected in series. 
Ettan MDLC increases the duty cycle of the MS instrument by using a combination 
of two parallel sets of RPC trap/RPC columns in a fully automated and synchronized 
setup. While the sample is run on the fist set of columns, equilibration is performed 
on the second set, which ensures uninterrupted sample analysis and a major 
improvement in productivity. The high-throughput configuration is designed for 
analysis of larger sample sets of less complex mixtures, e.g. digested gel plug. 
Sample injection is handled by Autosampler A-905, which enables automated 
injections of up to 384 samples. 
The Thermo Finnigan LTQ was configured in the high-throughput mode using two 
C18 traps and a 10 cm x 75mm PicoFrit column (Agilent). Ten microliters of the 
trypsin-digested peptides were injected using the MDLC. Peptides were eluted with 
a 180-minute gradient from 0.1% formic acid to 65% acetonitrile with 0.1% formic 
acid at a flow rate of 300 nLlmin. The Finnigan LTQ was run in positive ion mode 
using the nanospray source. 
Spray voltage: 1.8 kV 
Capillary temperature: 200.00C 
Capillary voltage: 44.00 
Tube lens Or): 220.00 
Full MS: 2000,200 mlz 
Data Dependent M S N S  Data Dependent MSNS.  The method used consisted of a 
continual cycle beginning with one scan of MS (scan one), which recorded all of the 
mlzvalues of the ions present at that moment in the gradient, followedby three 
rounds of MSIMS. The initial MSNS scan was of the first most-intense ion 
recorded from the MS scan. The second MSIMS scan was of the second most- 
intense ion recorded from scan one. The third M S N S  scan was the third most- 
intense ion recorded from scan one. Dynamic exclusion was activated which 
improves the protein identification capacity during the analysis. Dynamic exclusion 
prevents an abundant peptide ion, with a broad elution profile, from being continually 
selected for MSIMS. The intense ionsprevent other lower-abundance peptides from 
being selected. Ions that were selected for M S N S  were placed onto a list. While on 
this list, they will be excluded for aperiod of time sothat other ions may be selected. 
The exclusion time set in this study was 90 seconds. 
The data was searched using TurboSEQUEST in BioWorks 3.1, selecting 
modification by carboxymidomethlyation of cysteines (+57.02 Da) and partial 
modification of methionine (+14.03 Da). One internal trypsin cleavage site was 
allowed and a tolerance of 1.4Da for precursor ions. 
Iodacetamide is used in the 2DE process to prevent formation of disulfide bonds 
following IEF which reacts with cysteine residues forming S- 
carboxyamidomethylcysteine which adds +57.02Da to each modified cysteine 
(Lapko et al, 2000). Partial oxidation of methionines causes an addition of 14.03Da 
After acquisition of MSMS spectra, the software algorithm SEQUEST (Yates et al, 
1998) was employed for peptidelprotein identification. SEQUEST matches an 
MSMS spectrum with a peptide sequence using the following steps. (1) All 
theoretical peptides with molecular masses isobaric to that of the precursor ion for 
an MSMS spectrum are extracted from the database (SWISS-PROT). (2) Each 
peptide was given a preliminary score by examining the number of predicted 
fragment ions from the database peptide that match the acquired fragment ions in the 
MSMS spectrum. (3) The 500 best-matching peptides then undergo a more rigorous 
ion matching algorithm that generates a SEQUEST cross-correlation score (Xcorr). 
A list of the best matching peptides are returned with the top-scoring peptide being 
considered the best candidate (F'eng et al, 2003). 
Cross-correlation scores (XCom) are generated using the SEQUEST algorithm 
which takes into account fragment ions derived from precursor ions matching them 
to model spectra in the database. The Xcorr of a peptide is based on the "fit" of the 
MSIMS data to the theoretical distribution of ions produced for the peptide. 
A SEQUEST identification was deemed correct if it met the following criteria: 
XCorr > 1.5 for singly charged ions, XCorr > 2.0 for doubly charged ions, and 
XCorr > 2.5 for triply charged ions, peptide length was at least seven residues, at 
least 30% of predicted b/y ions were accounted for within the spectrum, the peptide 
was fully tryptic (containing a Lys or Arg residue on the C-terminus), and at least 
one other peptide from the same protein was identified (Frewen et al, 2006). 
Using these parameters, BioWorks identified seven proteins. Coverage was typically 
excellent, e.g., 36% coverage for bovine serum albumin from 13 peptides distributed 
throughout the protein. 
Peptide samples were trapped and concentrated on C18 trap columns before being 
separated using an acetonitrile gradient (0.1-65% over 180mins) through a C18 
reverse phase column. Peptides were analysed by MS and MSMS. Fragmented 
peptides were searched using S E Q U E S T ~ ~  against the SWISS PROT database. 
Spot 160-vinculin (figure 3.13. l), 810-Keratin 1 (figure 3.13.2), 1059-Beta Tubulin 
(figure 3.13.3), 22 13 Cytochrome C (figure 3.13.4), 1432 Cathepsin X (figure 
3.13.5) and 1678 Molecular Basis For The Local Confomational Rearrangement Of 
Human (figure 3.13.6) and 2104 Cytochrome C (figure 3.13.7) confirmed the protein 
identifications from the MALDI-TOF MS results. 
Spot 2 104 was not identified by MALDI-TOF MS however using nanoLC-Ion Trap 
Mass Spectrometery it was identified as Cytochrome C (figure 3.50). 
Results below show the full MS spectrum of all the peptide peaks eluted from the 
RPC column during the 180 minute Acetonitrile gradient. Relative abundance of the 
peaks is plotted against time. An individual MS spectrum shows the parent ions at 
any one time. The three most abundant ions are automatically selected for MSMS 
fragmentation and are then excluded from fragmentation for 90 seconds. The next 
three abundant peptides are then selected for fragmentation and they are then 
excluded for 90 seconds. Once a parent ion (peptide) selected it is fragmented with 
collisional energy to produce a fragmentation pattern of daughter ions (MSMS 
spectrum). 
There are three different types of bonds that can fragment along the amino acid 
backbone: the NH-CH, CH-CO and CO-NH bonds. Each bond breakage gives rise to 
two species, one neutral and the other one charged, and only the charged species is 
monitored by the mass spectrometer. The charge can stay on either of the two 
fragments depending on the chemistry and relative proton a f f i t y  of the two species. 
Hence there are six possible fragment ions for each amino acid residue and these are 
either a, b and c ions having the charge retained on the N-terminal fragment and x, y 
and z ions having the charge retained on the C-terminal fragment. The most 
common cleavage sites are at the CO-NH bonds which give rise to the b andlor the y 
ions. The mass difference between two adjacent b ions or y ions is indicative of a 
particular amino acid residue. 
In total 24 proteins were identified using a combination of MALDI-TOF MS and 
nanoLC-Ion trap MS. 
3.13.1 Master number: 160 
Identified by nanoLC-MSMS - Vinculin protein 
Having identified Vinculin by MALDI-TOF MS the remaining peptides were 
resuspended in 20pL of O.l%FA. The peptides were separated at 30OnLlmin over a 
long gradient 0-65% Acetonitrile in 180 minutes directly into an Ion Trap Mass 
Spectrometers where MS and MSMS analysis was carried out. Figure 3.44a shows a 
base peak chromatogram plotting Relative abundance vs Time of ions detected by 
the Mass Spectrometer. Two prominent peaks are the double charged species of 
trypsin 1 and trypsin 2 eluting at 55.87 and 80.71 minutes respectively. Peptides 
related to Vinculin are low abundant and not visually detected in this 
Chromatographic view. 
Figure 3.44b shows the full MS spectrum generated at 49 minutes into the gradient. 
Ions at 3 13,341,371 and 445dz are baseline peaks present at all times and are 
mixture of solvent peaks, plasticer peaks and silica peaks. These ions are on an 
exclusion list and no MSMS data is generated from them. The parent ion at 523dz 
is also on an exclusion list. This ion is the double charge species of tryspin 2 
(1 046mJz) and no MSMS data is generated from this ion. The parent ion at 736.0dz 
was automatically selected for MSMS fragmentation and figure 3.44~ shows the 
fragmentation pattern generated. Figure 3.44d shows the SEQUEST result of the 
fragmentation pattern generated in figure 3.44~. SEQUEST used crossed-correlation 
analysis between the experimental MSMS spectrum and theoretically generated 
mass spectra from peptide sequences with a similar molecular weight to the 
experimental parent ion. In this case the fragmentation ions generated from the 
parent ion at 736.0rnlz matches the majority of b and y ions associated with the 
amino acid sequence DPSASPGDAGEQAIR of the protein vinculin with a cross 
correlation (XCorr) score of 5.13. Twenty other peptide sequences relating to 
vinculin were identified in that experiment resulting in 26% amino acid coverage of 
the protein by MSMS analysis (figure 3.44e). 
Figure 3.44 (a). MS spectrum of eluate RPC separation Spot 160. The digested peptide sample 
was redissolved in RPC solvent A (0.1% formic acid), and injected onto Ettan MDLC equipped 
with a ZorbaxTM SB-300 C18 3.5 mm column. Peptides were eluted with RPC solvent B (0.1% 
formic acid, 86% acetonitrile) at a flow rate of approximately 300 nUmin and analyzed with a 
Rinnigan LTQ (Thermo Electron Corp.) fitted with a nanospray interface. 
Figure 3.44 (b) Mass spectrum for retention time 49.76. Parent Ion 736.0 mlz was chosen for 
MS/MS 
Figure 3.44 (c) MSIMS spectrum of the generated product ions from doubly charged ion 
7363mlz 
Ngnre 3.44 (e) BioWorks identified Vinculin (VCL protein-Homo sapiens) with a ./a amino reid 
coverage of 26.59% from 25 peptldes distriiuted throughout the pmtda 
3.13.2 Master number: 810 
Identified by nanoLC-MSMS - Keratin 1 protein 
Having identified Keratin by MALDI-TOE MS the remaining peptides were 
resuspended in 20pL of O.l%FA. These peptides were separated at 30OnLlmin over 
a long gradient 0-65% Acetonitrile in 180 minutes directly into an Ion Trap Mass 
Spectrometers where MS and MSMS analysis was carried out. Figure 3.45a shows a 
base peak chromatogram plotting Relative abundance vs Time of ions detected by 
the Mass Spectrometer. 
Figure 3.45b shows the full MS spectrum generated at 37.51 minutes into the 
gradient. Ions at 313,341,371 and 445mIz are contamination peaks present at all 
times and are mixture of solvent peaks, plasticer peaks and silica peaks. These ions 
are on an exclusion list so no MSMS data is generated from them. Four parent ions 
are present at 639.5dz, 767.5dz, 939.5dz and 1022.5dz are present in scan 4293 
at 58.1 minutes into the run (figure 3.45b). The parent ion at 639.5dz was 
automatically selected for MSMS fragmentation and figure 3 . 4 5 ~  shows the 
fragmentation pattern generated. Figure 3.45d shows the SEQUEST result of the 
fragmentation pattern generated in figure 3.45~. SEQUEST used crossed-correlation 
analysis between the experimental MSMS spectrum and theoretically generated 
mass spectra from peptide sequences with a similar molecular weight to the 
experimental parent ion. In this case the fragmentation ions generated from the 
parent ion at 639.5dz matches the majority of b and y ions associated with the 
amino acid sequence LALDLEIATYR of the protein Keratin with a cross correlation 
(XCorr) score of 4.44. Sixteen other peptide sequences relating to Keratin 1 were 
identified in that experiment resulting in 3 1% amino acid coverage of the protein by 
MSMS analysis (figure 3.45e). 
Figure 3.45 (a) MS spectrum of eluate from RPC separation of spot 810. The digested peptide 
sample was injected onto Ettan MDLC equipped with a ZorbaxTM SB-300 C18 3.5 mm column. 
Peptides were eluted with RPC solvent B (0.1% formic acid, 86% acetonitrile) at a now rate of 
approximately 300 Wmin and analyzed with a Finnigan LTQ (Thermo Electron Corp.) fitted 
with a nanospray interface. 
Figure 3.45 (b) (A) Mass spectrum for retention time 37.51 min. Parent Ion 6 3 9 . 5 ~ ~ 1 ~  was 
chosen for MSMS 
Figure 3.45 (c) MSIMS spectrum of the generated product ions from doubly charged ion 639.7 
Figure 3.45 (d) Bared on this analysis, the peptide LALDLEIATYR of the protein Keratin 1 
waa identifled 3A5e). TnrboSEQUESTru cmas wmlrtion (XCorr) - 4.44 
Figure 3.45 (e) BloWorLs identified Keratin l(Eomo aaplens) with a % amino add coverage of 
31.52% from 16 peptides dismbuted throughout the protein. 
3.13.3 Master number: 1059 
Identified by nanoLC-MSMS -Beta Tubulin 
Having identified Beta-Tublin by MALDI-TOF MS the remaining peptides were 
resuspended in 2 0 ~ L  of O.l%FA. These peptides were separated at 300nLImin over 
a long gradient 0-65% Acetonitrile in 180 minutes directly into an Ion Trap Mass 
Spectrometers where MS and MSMS analysis was carried out. Figure 3.46a shows a 
base peak chromatogram plotting Relative abundance vs Time of ions detected by 
the Mass Spectrometer. 
Figure 3.46b shows the full MS spectrum generated at 67.53 minutes into the 
gradient. The parent ion at 668.6 m/z was automatically selected for MSMS 
fragmentation and figure 3.46~ shows the fragmentation pattern generated. Figure 
3.46d shows the SEQUEST result of the fiagmentation pattern generated in figure 
3.46~. SEQUEST used crossed-correlation analysis between the experimental 
MSMS spectrum and theoretically generated mass spectra from peptide sequences 
with a similar molecular weight to the experimental parent ion. In this case the 
fragmentation ions generated from the parent ion at 668.6 m/z matches the majority 
of b and y ions associated with the amino acid sequence IMTFSVVPSPK of the 
protein Beta-tubulin with a cross correlation (XCorr) score of 4.69. Ten other 
peptide sequences relating to beta-tubulin were identified in that experiment 
resulting in 32.27% amino acid coverage of the protein by MSMS analysis (see 
figure 3.46e). 
Figure 3.46 (a) MS spectrum of eluate from RPC separation of spot 1059. The digested peptide 
sample was injected onto Ettan MDLC equipped with a ZorhaxTM SB-300 C18 3.5 mm column. 
Peptides were eluted with RPC solvent B (0.1% formic acid, 86% acetonitrile) at a flow rate of 
approximately 300 nYrnin and analyzed with a Finnigan LTQ (Thermo Electron Corp.) fitted 
with a nanospray interface. 

Figure 3.46 (c) MUMS spectrum of the generated product ions from doubly charged ion 668.6 
Eigure 3.46 (d) Baaed on this analysis, the peptide IMNTFSVVPSPK of the protein 
BetaTubulln w n  identified. TurboSEQUESP cross wmlrtbn (XCorr) = 4.69 
Figure 3.46 (e) BioWorks IdentifiedBeta Tubulln-human with a amino acid % coverage of 
3227H wvemge for Beta Tubulln from 11 peptides distributed throughout the protein 
3.13.4 Master number: 2213 
Identified by nanoLC-MSMS - Cytochrome c oxidase 
Having identified Cytochrome C by MALDI-TOF MS the remaining peptides were 
resuspended in 20pL of O.l%FA. These peptides were separated at 300nL/min over 
a long gradient 0-65% Acetonitrile in 180 minutes directly into an Ion Trap Mass 
Spectrometers where MS and MSMS analysis was carried out. Figure 3.47 shows a 
base peak chromatogram plotting Relative abundance vs Time of ions detected by 
the Mass Spectrometer.. 
Figure 3.47b shows the full MS spectrum generated at 22.83 minutes into the 
gradient. Ions at 33 1.5 and 502.91111~ were not selected for MSMS fragmentation as 
they are contamination peaks and are on an exclusion list. The parent ion at 403.9 
m/z was automatically selected for MSMS fragmentation and figure 3.47~ shows the 
fragmentation pattern generated. Figure 3.47d shows the SEQUEST result of the 
fragmentation pattern generated in figure 3.47~. SEQUEST used crossed-correlation 
analysis between the experimental MSMS spectnun and theoretically generated 
mass spectra from peptide sequences with a similar molecular weight to the 
experimental parent ion. In this case the fragmentation ions generated from the 
parent ion at 404.09 m/z matches the majority of b and y ions associated with the 
amino acid sequence AEGTFPGK of the protein Cytochrome C oxodase with a 
cross correlation (XCorr) score of 3.07. One other peptide sequence relating to 
Cytochrome C was identified in that experiment resulting in 18.39% amino acid 
coverage of the protein by MSMS analysis (figure 3.47e). 
Figure 3.47 (a) MS spectrum of eluate from RPC separation of spot 2113. The digested peptide 
sample was injected onto Ettan MDLC equipped with a Zorbaxm SB-300 C18 3.5 mm column. 
Peptides were eluted withRPC solvent B (0.1% f o d c  acid, 86% acetonitrile) at a flow rate of 
approximately 300 nYmin and analyzed with a Finnigan LTQ (Thermo Electron Corp.) fitted 
with a nanospray interface 
Figure 3.47 (b) Mass spectrum for retention time 22.83 min. Parent Ion 403.9mIz was chosen 
for MSIMS 
Figure 3.47 (c) MSMS spechvm of the generated product ions from doubly charged ion 404.0 
Figure 3.47 (d) Based on this analysis, the peptide AEGTFPGK of the protein Cytoehrome C 
was identitled (FLgoFe 3A7e). TorboSEQUESTrV cross wrdation (XCorr) = 3.07 
Figure 3.47 (e) BioWorks identifled Cytoduome C (Homo sapiena) with an amino add 
coverage of 18.39% coverage from 2 peplidea distributed throughout the protein 
3.14.5 Master number: 1432 
Identified by nanoLC-MSMS - Cathepsin X 
Having identified Cathespin X by MALDI-TOF MS the remaining peptides were 
resuspended in 20pL of O.l%FA. These peptides were separated at 300nLImin over 
a long gradient 0-65% Acetonitrile in 180 minutes directly into an Ion Trap Mass 
Spectrometers where MS and MSMS analysis was carried out. Figure 3.48a shows a 
base peak chromatogram plotting Relative abundance vs Time of ions detected by 
the Mass Spectrometer. 
Figure 3.48b shows the full MS spectrum generated at 54.38 minutes into the 
gradient. Ions at 313.4, 371.3,445.2 and 519.lm/z were not selected for MSMS 
fragmentation as they are contamination peaks and are on an exclusion list. Parent 
ion at 422.0dz was also on an exclusion list as the ion is the double charged species 
of Trypsin I (842dz). The parent ion at 655.1 d z  was automatically selected for 
MSMS fragmentation and figure 3.48~ shows the fragmentation pattern generated. 
Figure 3.48d shows the SEQUEST result of the fragmentation pattern generated in 
figure 3.48~. SEQUEST used crossed-correlation analysis between the experimental 
MSMS spectrum and theoretically generated mass spectra from peptide sequences 
with a similar molecular weight to the experimental parent ion. In this case the 
fragmentation ions generated from the parent ion at 655.1 d z  matches the majority 
of b and y ions associated with the amino acid sequence NVDGVNYASITR of the 
protein Cathepsin X with a cross correlation (XCorr) score of 4.69. Three other 
peptide sequence relating to Cathepsin X were identified in that experiment resulting 
in 12.87% amino acid coverage of the protein by MSMS analysis (figure 3.48e). 
Figure 3.48 (a) MS spectrum of eluate from RPC separation of spot 1432. The digested peptide 
sample was injected onto Ettan MDLC equipped with a ZorbaxTM SB-300 C18 3.5 mm column. 
Peptides were eluted with RPC solvent B (0.1% formic acid, 86% acetonitrile) at a flow rate of 
approximately 300 d m i n  and analyzed with a Finnigan LTQ (Thermo Electron Corp.) fitted 
with a nanospray interface 
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Figure 3.48 (b) Mass spectrum for retention time 5438 min. Parent Ion 655.1mlz was chosen 
for MSMS 
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Fignre 3.48 (e) MSlMS speetrum of the generated produet ions from doubly charged ion 655.29 
X was identified (Flgore 30e). TnrboSEQUES'FY cross correlation (XCorr) = 4.69 
Figure 3 4  (e) BioWorka idmtiBed Catbepsin X. Coverage wm lZ.87% coverage for Cathepsin 
X from 4 peptides distributed throughout the protein 
3.13.6 Master number: 1678 
Identified by nanoLC-MSMS - Protein Molecular Basis for the local 
eonformational rearrangement of human Phosphoserine Phosphatase 
Having identified Protein Molecular Basis for the local conformational 
rearrangement of human Phosphoserine Phosphatase by MALDI-TOF MS the 
remaining peptides were resuspended in 20pL of O.l%FA. The peptides were 
separated at 300nLImin over a long gradient 0-65% Acetonitrile in 180 minutes 
directly into an Ion Trap Mass Spectrometers where MS and MSMS analysis was 
carried out. Figure 3.49a shows a base peak chromatogram plotting Relative 
abundance vs Time of ions deteted by the Mass Spectrometer.' 
- ,.. ., . ., 
Figure 3.491, shows the N 1  MS spectrum generated at 88.96 minutes into the 
gradient. Ions at 313.4, 341.5,371.3,445.2 and 519.lm/z werenot selected for 
MSMS fragmentation as they are contamination peaks and are on an exclusion list. 
The parent ion at 669.0 d z  was automatically selected for MSMS fragmentation 
and figure 3.49~ shows the fragmentation pattern generated. Figure 3.49d shows the 
SEQUEST result of the fragmentation pattern generated in figure 3.49~. SEQUEST 
used crossed-correlation analysis between the experimental MSMS spectrum and 
theoretically generated mass spectra kom peptide sequences with a similar 
molecular weight to the experimental parent ion. In this case the fragmentation ions 
generated from the parent ion at 669.24 m/z matches the majority of b and y ions 
associated with the amino acid sequence NVQVFLISGGFR of the Protein 
Molecular Basis for the local conformational rearrangement of human 
Phosphoserine Phosphatase with a cross correlation (XCorr) score of 4.69. Eight 
other peptide sequences relating to Protein Molecular Basis for the local 
conformational rearrangement of human Phosphoserine Phosphatase was identified 
in that experiment resulting in 56.89% amino acid coverage of the protein by MSMS 
analysis (figure 3.49e). 
Figure 3.49 (a) MS spectrum of eluate from RPC separation of spot 1678. The digested peptide 
sample was injected onto Ettan MDLC equipped with a ZorbaxTM SB-300 C18 3.5 mm column. 
Peptides were eluted with RPC solvent B (0.1% formic acid, 86% acetonitrile) at a flow rate of 
approximately 300 dmin  and analyzed with a Finnigan LTQ (Thermo Electron Corp.) fitted 
with a nanospray interface 
ELI 
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Figure 3.49 (c) MSMS spectrum 
Figure 3.49 (d) Based on this analysis, the peptide N V Q W G G F R  of the protein Molecular 
Bash for the local conformational rearrangement of human Phosphoserine ~hos~hatase was 
identi6ed @gue 31e). TurboSEQUESllm cross correlation (XCorr) = 4.69 
rearrangement of human PhosphorerIm Phosphatase. Coverage wm 56.89% coverage for 
Moleenlv B.sis for the local c o n f o ~ n a l  rumngcment of human Phoaphoserine 
Phosphatase from 9 peptides distributed throughout the protein 
3.13.7 Master number: 2104 
Identified by nanoLC-MSMS - Cytochrome C 
MALDI-TOF MS was unable to identify spot number 2014. The peptides from spot 
2104 were analysed after dried droplet method and sample clean up with Zip Tip by 
MALDI-ToF MS analysis without success. The remaining peptides were 
resuspended in 20pL of O.l%FA. The peptides were separated at 300nL/min over a 
long gradient 0-65% Acetonitrile in 180 minutes directly into an Ion Trap Mass 
Spectrometers where MS and MSMS analysis was camed out. Figure 3.50a shows a 
base peak chromatogram plotting Relative abundance vs Time of ions detected by 
the Mass Spectrometer. 
Figure 3.50b shows the full MS spectrum generated at 40.40 minutes into the 
gradient. Ions at 313.4, 341.5,371.3,445.2 and 519.ldz were not selected for 
MSMS fragmentation as they are contamination peaks and are on an exclusion list. 
The very low abundant parent ion at 404.1 m/z was automatically selected for 
MSMS fragmentation and figure 3.50~ shows the fragmentation pattern generated. 
Figure 3.50d shows the SEQUEST result of the fragmentation pattern generated in 
figure 3.50~. SEQUEST used crossed-correlation analysis between the experimental 
MSMS spectrum and theoretically generated mass spectra from peptide sequences 
with a similar molecular weight to the experimental parent ion. In this case the 
fragmentation ions generated from the parent ion at 404.32 m/z matches the majority 
of b and y ions associated with the amino acid sequence AEGTFPGK of 
Cytochrome C Oxidase with a cross correlation (XCorr) score of 4.69. Eight other 
peptide sequences relating to Cytochrorne C oxidase was identified in that 
experiment resulting in 18.39% amino acid coverage of the protein by MSMS 
analysis (figure 3.50e). 
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Figure 3.50 (a) MS spectrum of eluate from RPC separation of spot 2213. The digested peptide 
sample was injected onto Ettan MDLC equipped with a Zorbaxm SB-300 C18 3.5 mm column. 
Peptides were eluted with RPC solvent B (0.1% formic acid, 86% acetonitrile) at a flow rate of 
approximately 300 d m i n  and analyzed with a Finnigan LTQ (Thermo Electron Corp.) fitted 
with a nanospray interface. 
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identified (Tigum 32e). TurboSEQUESF cross correlation (XCorr) = 4.69 
Figure 3.50 (e) BioWorks idenlified Cytochrome C. Coverage was 18.39% coverage for 
Cytochrome C from 2 peptides distributed tluoughout the protein 
3.14 Protein identification results from Tandem Mass Spectrometry 
Using nanoLC and Tandem Mass Spectrometry seven proteins were identified. 
Master spot numbers 160,810,1059, 1432, 1678 and 2104 confirmed with the 
protein identifications obtained by MALDI-MS. Master number 2213 was only 
identified by Tandem Mass Spectrometry 
The proteins identified by nanoLC-Tandem Mass Spectrometry can be seen below 
(table 3.5). 
Table 3.5. Summary of results of Tandem Mass Spectrometry results 
1432 
1678 
2104 
221 3 
-1.56 
1.58 
2.20 
3.09 
0.00031 
0.00019 
7.10E-07 
2.00E-09 
gi11264332IsolQ9UBR31CATZ - Human 
Cathepsln X 
gi129726390lpdbllL8\A Molecular Basls For 
The Local Conformatlonal Rearrangement 
Of Human Phosphoserlne Phosphatasel 
g11305827291gblAAP35591.1 - cytochrome 
c oxidase subunlt VIb [Homo saplens1 
g113055841gblAAP36312.1 - cytochrome c 
oxldase subunlt VIb lHomo sapiensl 
56.89 
18.39 
18.39 
5.53 
6.54 
6.54 
25.06 
10.30 
10.30 
3.15 Optimisation of MLDC nano-LC and LTQ MS/MS methods 
using lOOfmol Bovine Serum Albumin @SA) digest 
Using a commercially available BSA digest (Waters) at a concentration of 100fmol 
we looked at three different acetonitrile (ACN) gradients using the MDLC at flow 
rates of approximately 300nl/min to separate the peptides using ZorbaxTM SB-300 
C18 3.5 mrn column (Agilent) directly in the Finnigan LTQ (Thermo Electron 
Corp.) fitted with a nanospray interface. The data generated was searched using 
SEQUEST. 
The three gradients were 
1. Long Gradient O.l%FA - 65% ACN over 180mins 
2. Medium Gradient O.l%FA- 65%ACN over 120mins 
3. Short Gradient O.l%FA - 65% ACN over 6Omins 
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Figure 3.51 (a) MS spectrum of BSA digest using the long Gradient O.l%FA - 65% ACN over 
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Figure3.53 (a) MS spectrum of BSA digest using the long Gradient O.l%FA- 65% ACN over 
6Omins 
Using three different gradients to separate a single protein tryptic digest (in this case 
lOOfinol of BSA) indicated that all three methods were capable of separating the 
complex mix of 50 peptides. The long gradient 180mins resolved the peptides 
allowing a SEQUEST result for BSA giving coverage of 74% by amino acids and 
the medium gradient of 120mins gave slightly higher coverage of 75% for BSA by 
amino acids (figure 3.51+3.52). The short gradient at 60mins resolved the peptides 
enough to allow coverage of 71% for BSA by amino acid coverage (figure 3.53). 
5.0 Conclusions 
The main focus of this thesis was to optimise methods of Mass Spectrometry for 
protein identification. Proteins separated by 2D-gel electrophesis were stained with 
Coomasie blue and gel-plugs were subjected to in-gel digestion. 
Optimisation procedures included combination of MALDI-TOF MS data from Zip 
Tip and non-Zip Tip samples. The use of calibration strategies with trypsin 
autodigestion peaks, commercially available calibrations peaks and protein peptide 
peaks to obtain high confidence protein identifications. The use of larger gel plugs 
to enhance mass spectral information and obtain protein identifications from low 
molecular weight proteins. 
Setting up of liquid chromatography tandem mass spectrometry methods to allow 
for peptide sequence information 
Using these optimised protein identification methods we looked at the effects of 5- 
bromo-2'-deoxyuridine (BrdU) in the poorly differentiated lung carcinoma cell line 
DLKP using 2-DE gel electrophoresis and mass spectrometry. 
The following conclusions were made as a result of this study: 
Following treatment of DLKP with 10pM BrdU, DIGE technology allowed the 
comparison of BrdU treated DLKP versus control DLKP. Using three biological 
replicates, 43 statistically significant abundance changes between control and 
treated DLKP were identified. 
Using a combination of peptide clean up, calibration methods and increased volume 
of spot we increased the number proteins identified by MALDI-ToF MS possible 
compared to the high-throughput robotic methods currently in place in our 
laboratory. We identified 22 differentially regulated proteins using MALDI-ToF 
MS. 
Using nano-LC and tandem Mass spectrometry methods it was possible to confirm 
6 protein identifications that had been obtained by MALDI-ToF MS. An additional 
protein was identified by this method that was too low abundant for a MALDI-ToF 
MS identification. 
In total, 23 proteins were identified by Mass Spectrometry. These proteins were 
involved in cell growth, maintenance, metabolism and immune response. 
Through optimisation of the LC methods run times for sample identification were 
reduced from 180 minutes to 60 minutes with a minimal reduction of % amino acid 
coverage. 
Future work 
1. Time course study of the effects of BrdU on DLKP. During the course of this 
study DLKP was exposed to BrdU on day four and day seven. A global 
proteomic study using DIGE to examine the effects of BrdU on DLKP at a 
number of time points would be interesting. 
2. Fraction of DLKP-BrdU treated proteome. A limitation of the total proteomic 
experiment is the bias toward highly abundant proteins such as proteins 
involved in metabolism and those found in the cytoskeleton. Fractionation of 
the BrdU-treated DLKP proteome into nuclear, cytoplasmic, mitochondrial, 
membrane etc would reveal specific regulation of proteins involved in the 
various processes investigated. 
3. During the course we looked at a narrow range of protein f?om the total 
proteome (pH 4-7). Investigation of other ranges (e.g pH 3-5,6-11 etc.) could 
reveal other differentially regulated proteins. 
4. Western blotting will be used to confirm the identity of selected proteins 
obtained by Mass Spectrometry and to also confirm changes in expression 
level afte BrdU treatment. Imrnunocytochemistry and confocal microscopy 
will also be used to investigate the changes in protein expression, as protein 
function is often related to its location. Confocal microscopy will also allow 
for studies on protein interaction and co-localisation to be conducted. 
5. Use quantitative Mass Spectrometry to compare differentially regulated 
proteins obtained by ITRAQ labelling versus 2D-DIGE. 
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